U.S. patent application number 10/818633 was filed with the patent office on 2005-09-08 for plant protein disulfide isomerase.
Invention is credited to Cahoon, Rebecca E., Herrmann, Rafael, McCutchen, Bill F., Rafalski, J. Antoni.
Application Number | 20050198708 10/818633 |
Document ID | / |
Family ID | 34220946 |
Filed Date | 2005-09-08 |
United States Patent
Application |
20050198708 |
Kind Code |
A1 |
Cahoon, Rebecca E. ; et
al. |
September 8, 2005 |
Plant protein disulfide isomerase
Abstract
This invention relates to an isolated nucleic acid fragment
encoding a protein disulfide isomerase. The invention also relates
to the construction of a chimeric gene encoding all or a portion of
the protein disulfide isomerase, in sense or antisense orientation,
wherein expression of the chimeric gene results in production of
altered levels of the protein disulfide isomerase in a transformed
host cell.
Inventors: |
Cahoon, Rebecca E.; (Webster
Groves, MO) ; Rafalski, J. Antoni; (Wilmington,
DE) ; McCutchen, Bill F.; (Clive, IA) ;
Herrmann, Rafael; (Wilmington, DE) |
Correspondence
Address: |
E I DU PONT DE NEMOURS AND COMPANY
LEGAL PATENT RECORDS CENTER
BARLEY MILL PLAZA 25/1128
4417 LANCASTER PIKE
WILMINGTON
DE
19805
US
|
Family ID: |
34220946 |
Appl. No.: |
10/818633 |
Filed: |
April 6, 2004 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
10818633 |
Apr 6, 2004 |
|
|
|
09417251 |
Oct 13, 1999 |
|
|
|
6864403 |
|
|
|
|
60104426 |
Oct 15, 1998 |
|
|
|
Current U.S.
Class: |
800/280 ;
435/235.1; 435/419; 435/468; 435/5; 435/6.13; 536/23.6 |
Current CPC
Class: |
G01N 2333/99 20130101;
C12N 9/90 20130101 |
Class at
Publication: |
800/280 ;
435/006; 435/468; 435/419; 536/023.6; 435/235.1 |
International
Class: |
A01H 001/00; C12Q
001/68; C07H 021/04; C12N 005/04 |
Claims
1-15. (canceled)
16. An isolated polynucleotide comprising: (a) a nucleotide
sequence encoding a polypeptide having disulfide isomerase
activity, wherein the amino acid sequence of the polypeptide and
the amino acid sequence of SEQ ID NO:16 have at least 90% identity,
or (b) the complement of the nucleotide sequence, wherein the
complement and the nucleotide sequence contain the same number of
nucleotides and are 100% complementary.
17. The polynucleotide of claim 16 wherein the amino acid sequence
identity is at least 95%.
18. The polynucleotide of claim 16 wherein the polypeptide
comprises the amino acid sequence of SEQ ID NO:16.
19. The polynucleotide of claim 16 wherein the polynucleotide
comprises the nucleotide sequence of SEQ ID NO:15.
20. A chimeric gene comprising the polynucleotide of claim 16
operably linked to at least one regulatory sequence.
21. A cell comprising the polynucleotide of claim 16.
22. The cell of claim 21, wherein the cell is selected from the
group consisting of a yeast cell, a bacterial cell and a plant
cell.
23. A transgenic plant comprising the polynucleotide of claim
16.
24. A virus comprising the polynucleotide of claim 16.
25. A method for transforming a cell comprising introducing into a
cell the polynucleotide of claim 16.
26. A method for producing a transgenic plant comprising (a)
transforming a plant cell with the polynucleotide of claim 16 and
(b) regenerating a plant from the transformed plant cell.
27. A vector comprising the polynucleotide of claim 16.
28. A seed comprising the chimeric gene of claim 20.
29. A method for isolating a polypeptide encoded by the
polynucleotide of claim 16 comprising isolating the polypeptide
from a cell transformed with said polynucleotide.
30. A composition comprising an isolated polynucleotide comprising
a nucleotide sequence encoding a first polypeptide of at least 100
amino acids that has at least 85% identity based on the Clustal
method of alignment when compared to a polypeptide selected from
the group consisting of a polypeptide of SEQ ID NOs:2, 4, 6, 8, 10,
12, 14, 16, 18, and 20, or an isolated polynucleotide comprising
the complement of the nucleotide sequence.
Description
[0001] This application claims the benefit of U.S. Provisional
Application No. 60/049,408, filed Oct. 15, 1998.
FIELD OF THE INVENTION
[0002] This invention is in the field of plant molecular biology.
More specifically, this invention pertains to nucleic acid
fragments encoding protein disulfide isomerases in plants and
seeds.
BACKGROUND OF THE INVENTION
[0003] Protein folding requires the assistance of folding helpers
in vivo. The formation or isomerization of disulfide bonds in
proteins is a slow process requiring catalysis. In nascent
polypeptide chains the cysteine residues are in the thiol form. The
formation of the disulfide bonds usually occurs simultaneously with
the folding of the polypeptide, in the endoplasmic reticulum of
eukaryotes or in the periplasm of Gram-negative bacteria. Cells
contain three types of accessory proteins that function to assist
polypeptides in folding to their native conformations: protein
disulfide isomerases, propyl cis-trans isomerases, and molecular
chaperones.
[0004] Protein disulfide isomerase (PDI) is a homodimeric
eukaryotic enzyme which catalyzes disulfide interchange reactions.
PDI is also thought to be the beta subunit of the heterotetramer
prolyl hydrolase, the enzyme that hydroxylates the proline residues
in Collagen. PDI appears to belong to a family of closely related
proteins which have specific functions. PDI (EC 5.3.4.1), also
called S-S rearrangase, catalyzes the rearrangement of both
intrachain and interchain disulfide bonds in proteins to form
native structures. The reaction depends on sulfhydryl-disulfide
interchange, and PDI needs reducing agents or partly-reduced
enzyme. A family of PDI-like proteins has been identified in
mammals, yeasts, fungi, plants, and Drosophila.
[0005] In Drosophila, a PDI precursor was identified by screening a
genomic DNA library at reduced stringency hybridization conditions
using a rat Phospholipase C alpha cDNA probe. Northern analysis
showed that this gene encodes a transcript that is present
throughout development, in heads and bodies of adults. The encoded
protein contains two domains exhibiting high similarity to
thioredoxin, two regions that are similar to the hormone binding
domain of human estrogen receptor, and a C-terminal ER-retention
signal (KDEL). Overall, this Drosophila PDI gene contains a higher
similarity to rat protein disulfide isomerase (53% identical) than
to rat Phospholipase C alpha (30% identical) (McKay et al. (1995)
Insect Biochem. Mol. Biol. 25:647-654).
[0006] Another member of the PDI family is ERp60, a PDI isoform
initially misidentified as a phosphatidylinositol-specific
phospholipase C. The human and Drosophila ERp60 polypeptides have
been cloned and expressed. These two ERp60 polypeptides are similar
to human PDI within almost all their domains, the only exception
being the extreme C-terminal region. Coexpression in insect cells
of the human or Drosophila ERp60 with the alpha subunit of human
propyl 4-hydrolase does not result in tetramer formation or prolyl
4-hydroxylase activity in the cells. This lack of tetramer
formation is not only due to the differences in the C-terminal
region since no prolyl 4-hydroxylase tetramer is formed when a
human ERp60 hybrid containing the C-terminal region of the human
PDI polypeptide is used (Koivunen et al. (1996) Biochem. J.
316:599-605). The 5' flanking region of the ERp60 gene has no TATAA
box or CCAAT motif but contains several potential binding sites for
transcription factors. The highest levels of expression of the
human ERp60 mRNA are found in the liver, placenta, lung, pancreas,
and kidney, and the lowest in the heart, skeletal muscle, and
brain. The ERp60 gene has been mapped by fluorescence in situ
hybridization to 15q15, a different chromosome than where the human
PDI and thioredoxin genes are found (Koivunen et al. (1997)
Genomics 42:397-404).
[0007] Full-length cDNA clones encoding two members of the mice PDI
family have been cloned, sequenced, and expressed (ERp59/PDI and
ERp72). ERp59/PDI has been identified as the microsomal PDI. The
ERp72 amino acid sequence shares sequence identity with ERp59/PDI
at three discrete regions, having three copies of the sequences
that are thought to be the CGHC-containing active sites of
ERp59/PDI. ERp59/PDI has the sequence Lys-Asp-Glu-Leu at its COOH
terminus while ERp72 has the related sequence Lys-Glu-Glu-Leu
(Mazzarella et al. (1990) J. Biol. Chem. 265:1094-1101). A cDNA
clone containing sequence similarity to the mammalian lumenal
endoplasmic reticulum protein ERp72 has been isolated from an
alfalfa (Medicago sativa L.) cDNA library by screening with a cDNA
encoding human PDI. The polypeptide encoded by this cDNA possesses
a putative N-terminal secretory signal sequence and two regions
identical to the active sites of PDI and ERp72. This protein
appears to be encoded by a small gene family in alfalfa, whose
transcripts are constitutively expressed in all major organs of the
plant. In alfalfa cell suspension cultures, ERp72 transcripts are
induced by treatment with tunicamycin, but not in response to
calcium ionophore, heat shock or fungal elicitor (Shorrosh and
Dixon (1992) Plant J. 2:51-58).
[0008] Another member of the PDI family is ERp5. The amino acid
sequence deduced from this cDNA insert contains two copies of the
11-amino-acid sequence Val-Glu-Phe-Tyr-Ala-Pro-Trp-Cys-Gly-His-Cys.
Duplicate copies of this sequence are found in the active sites of
rat and human PDI and in Form I phosphoinositide-specific
phospholipase C. Genomic sequences similar to the cDNA clone are
amplified 10-20-fold in hamster cells selected for resistance to
increasing concentrations of hydroxyurea, a phenomenon observed
earlier with cDNA clones for the M2 subunit of ribonucleotide
reductase and ornithine decarboxylase. RNA blots probed with ERp5
cDNA show two poly(A)+ RNA species which are elevated in
hydroxyurea-resistant cells (Chaudhuri et. al. (1992) Biochem. J.
281:645-650).
[0009] A PDI-like protein from Acanthamoeba castellanii contains
two highly conserved thioredeoxin-like domains, each about 100
amino acids. However, the A. castellanii PDI-like protein differs
from other members in many aspects, including the overall
organization and isoelectric point. Southern and Northern analyses
demonstrate that the PDI-like protein is encoded by a single-copy
gene which is transcribed to generate a 1500-nucleotide mRNA (Wong
and Bateman (1994) Gene 150:175-179).
[0010] The Chlamydomonas RB60 gene encodes a chloroplast-localized
PDI which is involved in the redox-regulated binding of chloroplast
poly(A)-binding protein to the 5'-leader region of psbA mRNA.
Protein disulfide isomerase RB60 regulates chloroplast
translational activation (Kim and Mayfield (1997) Science
278:1954-1957).
[0011] High level gene expression does not always lead to
corresponding high level secretion of heterologous proteins. The
rate limiting step has been shown, in many cases, to be the
processing and exit of the protein from the endoplasmic reticulum.
Proteins or peptides with high levels of disulfide bonds can be
adversely affected during expression. Therefore, coexpression
and/or overexpression of PDIs could significantly enhance
expression levels of many heterologous proteins. An example would
be the coexpression of PDIs with insect-selective neurotoxins,
since many of these are highly enriched in cysteines and feature
multiple disulfide bonds.
[0012] Protein disulfide isomerases have been described in alfalfa
(2 genes and one probable PDI P5 homolog), barley (2 genes, and one
probable PDI P5 homolog), maize, wheat, tobacco, and castor bean.
In addition, based on sequence similarity to other known PDIs, two
putative protein disulfide isomerases have been identified in
Arabidopsis. Included in this application are corn, and soybean
ESTs with sequence similarities to protein disulfide isomerase
precursor. The corn sequences included share no similarity with the
known maize PDI. Also included are corn, balsam pear, soybean, and
the wheat ESTs with sequence similarities to RB60. Presently there
are no plant RB60-homologs in the public domain. Overexpression of
any of these PDIs together with another foreign protein will result
in an increased yield of secreted, active foreign protein due to
proper folding of the foreign protein.
[0013] Present in the NCBI database are corn and soybean sequences
with similarities to the polynucleotides included in the present
application. These ESTs have NCBI General Identifier NOs:4289796,
4827500, 5124153, 5325044, 5361231, 5525515, 5597319, 5650368,
5688597, 5714111, 5770161, and 5804735.
SUMMARY OF THE INVENTION
[0014] The present invention relates to isolated polynucleotides
comprising a nucleotide sequence encoding a protein disulfide
isomerase precursor polypeptide of at least 100 amino acids that
has at least 85% identity based on the Clustal method of alignment
when compared to a polypeptide selected from the group consisting
of a corn protein disulfide isomerase precursor polypeptide
selected from the group consisting of SEQ ID NO:2, and SEQ ID NO:6,
a soybean protein disulfide isomerase precursor polypeptide of SEQ
ID NO:4. The present invention relates to isolated polynucleotides
comprising a nucleotide sequence encoding an RB60 polypeptide of at
least 100 amino acids that has at least 85% identity based on the
Clustal method of alignment when compared to a polypeptide selected
from the group consisting of a balsam pear RB60 polypeptide of SEQ
ID NO:8, a corn RB60 polypeptide selected from the group consisting
of SEQ ID NO:10 and SEQ ID NO:12, a soybean RB60 polypeptide
selected from the group consisting of SEQ ID NO:14 and SEQ ID
NO:16, and a wheat RB60 polypeptide selected from the group
consisting of SEQ ID NO:18 and SEQ ID NO:20. The present invention
also relates to an isolated polynucleotide comprising the
complement of the nucleotide sequences described above.
[0015] It is preferred that the isolated polynucleotides of the
claimed invention consist of a nucleic acid sequence selected from
the group consisting of SEQ ID NOs:1, 3, 5, 7, 9, 11, 13, 15, 17,
and 19 that codes for the polypeptide selected from the group
consisting of SEQ ID NOs:2, 4, 6, 8, 10, 12, 14, 16, 18 and 20. The
present invention also relates to an isolated polynucleotide
comprising a nucleotide sequences of at least one of 40 (preferably
at least one of 30, most preferably at least one of 15) contiguous
nucleotides derived from a nucleotide sequence selected from the
group consisting of SEQ ID NOs:1, 3, 5, 7, 9, 11, 13, 15, 17, and
19 and the complement of such nucleotide sequences.
[0016] The present invention relates to a chimeric gene comprising
an isolated polynucleotide of the present invention operably linked
to suitable regulatory sequences.
[0017] The present invention relates to an isolated host cell
comprising a chimeric gene of the present invention or an isolated
polynucleotide of the present invention. The host cell may be
eukaryotic, such as a yeast or a plant cell, or prokaryotic, such
as a bacterial cell or virus. A virus host cell of the present
invention is preferably a baculovirus. The baculovirus preferably
comprises an isolated polynucleotide of the present invention or a
chimeric gene of the present invention.
[0018] The present invention relates to a process for producing an
isolated host cell comprising a chimeric gene of the present
invention or an isolated polynucleotide of the present invention,
the process comprising either transforming or transfecting an
isolated compatible host cell with a chimeric gene or isolated
polynucleotide of the present invention.
[0019] The present invention relates to a protein disulfide
isomerase precursor or an RB60 polypeptide of at least 100 amino
acids comprising at least 85% homology based on the Clustal method
of alignment compared to a polypeptide selected from the group
consisting of SEQ ID NOs:2, 4, 6, 8, 10, 12, 14, 16, 18, and
20.
[0020] The present invention relates to a method of selecting an
isolated polynucleotide that affects the level of expression of a
protein disulfide isomerase precursor or an RB60 polypeptide in a
host cell, the method comprising the steps of:
[0021] constructing an isolated polynucleotide of the present
invention or an isolated chimeric gene of the present
invention;
[0022] introducing the isolated polynucleotide or the isolated
chimeric gene into a host cell (preferably a plant cell);
[0023] measuring the level a protein disulfide isomerase precursor
or an RB60 polypeptide in the plant cell containing the isolated
polynucleotide; and
[0024] comparing the level of a protein disulfide isomerase
precursor or an RB60 polypeptide in the host cell containing the
isolated polynucleotide with the level of a protein disulfide
isomerase precursor or an RB60 polypeptide in a host cell that does
not contain the isolated polynucleotide.
[0025] The present invention relates to a method of obtaining a
nucleic acid fragment encoding a substantial portion of a protein
disulfide isomerase precursor or an RB60 polypeptide gene,
preferably a plant protein disulfide isomerase precursor or an RB60
polypeptide gene, comprising the steps of: synthesizing an
oligonucleotide primer comprising a nucleotide sequence of at least
one of 40 (preferably at least one of 30, most preferably at least
one of 15) contiguous nucleotides derived from a nucleotide
sequence selected from the group consisting of SEQ ID NOs:1, 3, 5,
7, 9, 11, 13, 15, 17, and 19 and the complement of such nucleotide
sequences; and amplifying a nucleic acid fragment (preferably a
cDNA inserted in a cloning vector) using the oligonucleotide
primer. The amplified nucleic acid fragment preferably will encode
a portion of a protein disulfide isomerase precursor or an RB60
amino acid sequence.
[0026] The present invention also relates to a method of obtaining
a nucleic acid fragment encoding all or a subsantial portion of the
amino acid sequence encoding a protein disulfide isomerase
precursor or an RB60 polypeptide comprising the steps of: probing a
cDNA or genomic library with an isolated polynucleotide of the
present invention; identifying a DNA clone that hybridizes with an
isolated polynucleotide of the present invention; isolating the
identified DNA clone; and sequencing the cDNA or genomic fragment
that comprises the isolated DNA clone.
BRIEF DESCRIPTION OF THE SEQUENCE LISTING
[0027] The invention can be more fully understood from the
following detailed description and the accompanying Sequence
Listing which form a part of this application.
[0028] Table 1 lists the polypeptides that are described herein,
the designation of the cDNA clones that comprise the nucleic acid
fragments encoding polypeptides representing all or a substantial
portion of these polypeptides, and the corresponding identifier
(SEQ ID NO:) as used in the attached Sequence Listing. The sequence
descriptions and Sequence Listing attached hereto comply with the
rules governing nucleotide and/or amino acid sequence disclosures
in patent applications as set forth in 37 C.F.R.
.sctn.1.821-1.825.
1TABLE 1 Protein Disulfide Isomerases SEQ ID NO: Protein Clone
Designation (Nucleotide) (Amino Acid) Corn PDI precursor
cr1n.pk0090.d2 1 2 Soybean PDI srr3c.pk002.a8 3 4 precursor Corn
PDI precursor csi1.pk0032.c9 5 6 Balsam Pear RB60 fds.pk0022.c11 7
8 Corn PDI RB60 Contig of: 9 10 cen3n.pk0155.e7 cs1.pk0100.a7
p0032.crcbb52r p0125.czabp07r Corn PDI RB60 cs1.pk0077.f10 11 12
Soybean PDI RB60 sr1.pk0095.e9 13 14 Soybean PDI RB60 Contig of: 15
16 scr1c.pk005.i17 sdp2c.pk038.e22 sdp3c.pk021.a3 sfl1.pk0026.h1
sl2.pk0075.b10 Wheat PDI RB60 wl1n.pk0027.f4 17 18 Wheat PDI RB60
wre1n.pk0015.d10 19 20
[0029] The Sequence Listing contains the one letter code for
nucleotide sequence characters and the three letter codes for amino
acids as defined in conformity with the IUPAC-IUBMB standards
described in Nucleic Acids Res. 13:3021-3030 (1985) and in the
Biochemical J. 219 (No. 2):345-373 (1984) which are herein
incorporated by reference. The symbols and format used for
nucleotide and amino acid sequence data comply with the rules set
forth in 37 C.F.R. .sctn.1.822.
DETAILED DESCRIPTION OF THE INVENTION
[0030] In the context of this disclosure, a number of terms shall
be utilized. As used herein, a "polynucleotide" is a nucleotide
sequence such as a nucleic acid fragment. A polynucleotide may be a
polymer of RNA or DNA that is single- or double-stranded, that
optionally contains synthetic, non-natural or altered nucleotide
bases. A polynucleotide in the form of a polymer of DNA may be
comprised of one or more segments of cDNA, genomic DNA, or
synthetic DNA. An isolated polynucleotide of the present invention
may include at least one of 40 contiguous nucleotides, preferably
at least one of 30 contiguous nucleotides, most preferably one of
at least 15 contiguous nucleotides, of the nucleic acid sequence of
the SEQ ID NOs:1, 3, 5, 7, 9, 11, 13, 15, 17, or 19.
[0031] As used herein, "contig" refers to a nucleotide sequence
that is assembled from two or more constituent nucleotide sequences
that share common or overlapping regions of sequence homology. For
example, the nucleotide sequences of two or more nucleic acid
fragments can be compared and aligned in order to identify common
or overlapping sequences. Where common or overlapping sequences
exist between two or more nucleic acid fragments, the sequences
(and thus their corresponding nucleic acid fragments) can be
assembled into a single contiguous nucleotide sequence.
[0032] As used herein, "substantially similar" refers to nucleic
acid fragments wherein changes in one or more nucleotide bases
results in substitution of one or more amino acids, but do not
affect the functional properties of the polypeptide encoded by the
nucleotide sequence. "Substantially similar" also refers to nucleic
acid fragments wherein changes in one or more nucleotide bases does
not affect the ability of the nucleic acid fragment to mediate
alteration of gene expression by gene silencing through for example
antisense or co-suppression technology. "Substantially similar"
also refers to modifications of the nucleic acid fragments of the
instant invention such as deletion or insertion of one or more
nucleotides that do not substantially affect the functional
properties of the resulting transcript vis--vis the ability to
mediate gene silencing or alteration of the functional properties
of the resulting protein molecule. It is therefore understood that
the invention encompasses more than the specific exemplary
nucleotide or amino acid sequences and includes functional
equivalents thereof.
[0033] Substantially similar nucleic acid fragments may be selected
by screening nucleic acid fragments representing subfragments or
modifications of the nucleic acid fragments of the instant
invention, wherein one or more nucleotides are substituted, deleted
and/or inserted, for their ability to affect the level of the
polypeptide encoded by the unmodified nucleic acid fragment in a
plant or plant cell. For example, a substantially similar nucleic
acid fragment representing at least one of 30 contiguous
nucleotides derived from the instant nucleic acid fragment can be
constructed and introduced into a plant or plant cell. The level of
the polypeptide encoded by the unmodified nucleic acid fragment
present in a plant or plant cell exposed to the substantially
similar nucleic fragment can then be compared to the level of the
polypeptide in a plant or plant cell that is not exposed to the
substantially similar nucleic acid fragment.
[0034] For example, it is well known in the art that antisense
suppression and co-suppression of gene expression may be
accomplished using nucleic acid fragments representing less than
the entire coding region of a gene, and by nucleic acid fragments
that do not share 100% sequence identity with the gene to be
suppressed. Moreover, alterations in a nucleic acid fragment which
result in the production of a chemically equivalent amino acid at a
given site, but do not effect the functional properties of the
encoded polypeptide, are well known in the art. Thus, a codon for
the amino acid alanine, a hydrophobic amino acid, may be
substituted by a codon encoding another less hydrophobic residue,
such as glycine, or a more hydrophobic residue, such as valine,
leucine, or isoleucine. Similarly, changes which result in
substitution of one negatively charged residue for another, such as
aspartic acid for glutamic acid, or one positively charged residue
for another, such as lysine for arginine, can also be expected to
produce a functionally equivalent product. Nucleotide changes which
result in alteration of the N-terminal and C-terminal portions of
the polypeptide molecule would also not be expected to alter the
activity of the polypeptide. Each of the proposed modifications is
well within the routine skill in the art, as is determination of
retention of biological activity of the encoded products.
Consequently, an isolated polynucleotide comprising a nucleotide
sequence of at least one of 40 (preferably at least one of 30, most
preferably at least one of 15) contiguous nucleotides derived from
a nucleotide sequence selected from the group consisting of SEQ ID
NOs:1, 3, 5, 7, 9, 11, 13, 15, 17, 19 and the complement of such
nucleotide sequences may be used in methods of selecting an
isolated polynucleotide that affects the expression of a
polypeptide (such as PDI precursor or PDI RB60) in a host cell. A
method of selecting an isolated polynucleotide that affects the
level of expression of a polypeptide in a host cell (eukaryotic,
such as plant, or prokarotic such as yeast bacterial or virus) may
comprise the steps of: constructing an isolated polynucleotide of
the present invention or an isolated chimeric gene of the present
invention; introducing the isolated polynucleotide or the isolated
chimeric gene into a host cell; measuring the level a polypeptide
in the host cell containing the isolated polynucleotide; and
comparing the level of a polypeptide in the host cell containing
the isolated polynucleotide with the level of a polypeptide in a
host cell that does not contain the isolated polynucleotide.
[0035] Moreover, substantially similar nucleic acid fragments may
also be characterized by their ability to hybridize. Estimates of
such homology are provided by either DNA-DNA or DNA-RNA
hybridization under conditions of stringency as is well understood
by those skilled in the art (Haames and Higgins, Eds. (1985)
Nucleic Acid Hybridisation, IRL Press, Oxford, U.K.). Stringency
conditions can be adjusted to screen for moderately similar
fragments, such as homologous sequences from distantly related
organisms, to highly similar fragments, such as genes that
duplicate functional enzymes from closely related organisms.
Post-hybridization washes determine stringency conditions. One set
of preferred conditions uses a series of washes starting with
6.times.SSC, 0.5% SDS at room temperature for 15 min, then repeated
with 2.times.SSC, 0.5% SDS at 45.degree. C. for 30 min, and then
repeated twice with 0.2.times.SSC, 0.5% SDS at 50.degree. C. for 30
min. A more preferred set of stringent conditions uses higher
temperatures in which the washes are identical to those above
except for the temperature of the final two 30 min washes in
0.2.times.SSC, 0.5% SDS was increased to 60.degree. C. Another
preferred set of highly stringent conditions uses two final washes
in 0.1.times.SSC, 0.1% SDS at 65.degree. C.
[0036] Substantially similar nucleic acid fragments of the instant
invention may also be characterized by the percent identity of the
amino acid sequences that they encode to the amino acid sequences
disclosed herein, as determined by algorithms commonly employed by
those skilled in this art. Suitable nucleic acid fragments
(isolated polynucleotides of the present invention) encode
polypeptides that are 80% identical to the amino acid sequences
reported herein. Preferred nucleic acid fragments encode amino acid
sequences that are 85% identical to the amino acid sequences
reported herein. More preferred nucleic acid fragments encode amino
acid sequences that are 90% identical to the amino acid sequences
reported herein. Most preferred are nucleic acid fragments that
encode amino acid sequences that are 95% identical to the amino
acid sequences reported herein. Suitable nucleic acid fragments not
only have the above identities but typically encode a polypeptide
having at least 50 amino acids, preferably 100 amino acids, more
preferably 150 amino acids, still more preferably 200 amino acids,
and most preferably 250 amino acids. Sequence alignments and
percent identity calculations were performed using the Megalign
program of the LASERGENE bioinformatics computing suite (DNASTAR
Inc., Madison, Wis.). Multiple alignment of the sequences was
performed using the Clustal method of alignment (Higgins and Sharp
(1989) CABIOS. 5:151-153) with the default parameters (GAP
PENALTY=10, GAP LENGTH PENALTY=10). Default parameters for pairwise
alignments using the Clustal method were KTUPLE 1, GAP PENALTY=3,
WINDOW=5 and DIAGONALS SAVED=5.
[0037] A "substantial portion" of an amino acid or nucleotide
sequence comprises an amino acid or a nucleotide sequence that is
sufficient to afford putative identification of the protein or gene
that the amino acid or nucleotide sequence comprises. Amino acid
and nucleotide sequences can be evaluated either manually by one
skilled in the art, or by using computer-based sequence comparison
and identification tools that employ algorithms such as BLAST
(Basic Local Alignment Search Tool; Altschul et al. (1993) J. Mol.
Biol. 215:403-410; see also www.ncbi.nlm.nih.gov/BLAST- /). In
general, a sequence of ten or more contiguous amino acids or thirty
or more contiguous nucleotides is necessary in order to putatively
identify a polypeptide or nucleic acid sequence as homologous to a
known protein or gene. Moreover, with respect to nucleotide
sequences, gene-specific oligonucleotide probes comprising 30 or
more contiguous nucleotides may be used in sequence-dependent
methods of gene identification (e.g., Southern hybridization) and
isolation (e.g., in situ hybridization of bacterial colonies or
bacteriophage plaques). In addition, short oligonucleotides of 12
or more nucleotides may be used as amplification primers in PCR in
order to obtain a particular nucleic acid fragment comprising the
primers. Accordingly, a "substantial portion" of a nucleotide
sequence comprises a nucleotide sequence that will afford specific
identification and/or isolation of a nucleic acid fragment
comprising the sequence. The instant specification teaches amino
acid and nucleotide sequences encoding polypeptides that comprise
one or more particular plant proteins. The skilled artisan, having
the benefit of the sequences as reported herein, may now use all or
a substantial portion of the disclosed sequences for purposes known
to those skilled in this art. Accordingly, the instant invention
comprises the complete sequences as reported in the accompanying
Sequence Listing, as well as substantial portions of those
sequences as defined above.
[0038] "Codon degeneracy" refers to divergence in the genetic code
permitting variation of the nucleotide sequence without effecting
the amino acid sequence of an encoded polypeptide. Accordingly, the
instant invention relates to any nucleic acid fragment comprising a
nucleotide sequence that encodes all or a substantial portion of
the amino acid sequences set forth herein. The skilled artisan is
well aware of the "codon-bias" exhibited by a specific host cell in
usage of nucleotide codons to specify a given amino acid.
Therefore, when synthesizing a nucleic acid fragment for improved
expression in a host cell, it is desirable to design the nucleic
acid fragment such that its frequency of codon usage approaches the
frequency of preferred codon usage of the host cell.
[0039] "Synthetic nucleic acid fragments" can be assembled from
oligonucleotide building blocks that are chemically synthesized
using procedures known to those skilled in the art. These building
blocks are ligated and annealed to form larger nucleic acid
fragments which may then be enzymatically assembled to construct
the entire desired nucleic acid fragment. "Chemically synthesized",
as related to nucleic acid fragment, means that the component
nucleotides were assembled in vitro. Manual chemical synthesis of
nucleic acid fragments may be accomplished using well established
procedures, or automated chemical synthesis can be performed using
one of a number of commercially available machines. Accordingly,
the nucleic acid fragments can be tailored for optimal gene
expression based on optimization of nucleotide sequence to reflect
the codon bias of the host cell. The skilled artisan appreciates
the likelihood of successful gene expression if codon usage is
biased towards those codons favored by the host. Determination of
preferred codons can be based on a survey of genes derived from the
host cell where sequence information is available.
[0040] "Gene" refers to a nucleic acid fragment that expresses a
specific protein, including regulatory sequences preceding (5'
non-coding sequences) and following (3' non-coding sequences) the
coding sequence. "Native gene" refers to a gene as found in nature
with its own regulatory sequences. "Chimeric gene" refers any gene
that is not a native gene, comprising regulatory and coding
sequences that are not found together in nature. Accordingly, a
chimeric gene may comprise regulatory sequences and coding
sequences that are derived from different sources, or regulatory
sequences and coding sequences derived from the same source, but
arranged in a manner different than that found in nature.
"Endogenous gene" refers to a native gene in its natural location
in the genome of an organism. A "foreign" gene refers to a gene not
normally found in the host organism, but that is introduced into
the host organism by gene transfer. Foreign genes can comprise
native genes inserted into a non-native organism, or chimeric
genes. A "transgene" is a gene that has been introduced into the
genome by a transformation procedure.
[0041] "Coding sequence" refers to a nucleotide sequence that codes
for a specific amino acid sequence. "Regulatory sequences" refer to
nucleotide sequences located upstream (5' non-coding sequences),
within, or downstream (3' non-coding sequences) of a coding
sequence, and which influence the transcription, RNA processing or
stability, or translation of the associated coding sequence.
Regulatory sequences may include promoters, translation leader
sequences, introns, and polyadenylation recognition sequences.
[0042] "Promoter" refers to a nucleotide sequence capable of
controlling the expression of a coding sequence or functional RNA.
In general, a coding sequence is located 3' to a promoter sequence.
The promoter sequence consists of proximal and more distal upstream
elements, the latter elements often referred to as enhancers.
Accordingly, an "enhancer" is a nucleotide sequence which can
stimulate promoter activity and may be an innate element of the
promoter or a heterologous element inserted to enhance the level or
tissue-specificity of a promoter. Promoters may be derived in their
entirety from a native gene, or be composed of different elements
derived from different promoters found in nature, or even comprise
synthetic nucleotide segments. It is understood by those skilled in
the art that different promoters may direct the expression of a
gene in different tissues or cell types, or at different stages of
development, or in response to different environmental conditions.
Promoters which cause a nucleic acid fragment to be expressed in
most cell types at most times are commonly referred to as
"constitutive promoters". New promoters of various types useful in
plant cells are constantly being discovered; numerous examples may
be found in the compilation by Okamuro and Goldberg (1989)
Biochemistry of Plants 15:1-82. It is further recognized that since
in most cases the exact boundaries of regulatory sequences have not
been completely defined, nucleic acid fragments of different
lengths may have identical promoter activity.
[0043] The "translation leader sequence" refers to a nucleotide
sequence located between the promoter sequence of a gene and the
coding sequence. The translation leader sequence is present in the
fully processed mRNA upstream of the translation start sequence.
The translation leader sequence may affect processing of the
primary transcript to mRNA, mRNA stability or translation
efficiency. Examples of translation leader sequences have been
described (Turner and Foster (1995) Mol. Biotechnol.
3:225-236).
[0044] The "3' non-coding sequences" refer to nucleotide sequences
located downstream of a coding sequence and include polyadenylation
recognition sequences and other sequences encoding regulatory
signals capable of affecting mRNA processing or gene expression.
The polyadenylation signal is usually characterized by affecting
the addition of polyadenylic acid tracts to the 3' end of the mRNA
precursor. The use of different 3' non-coding sequences is
exemplified by Ingelbrecht et al. (1989) Plant Cell 1:671-680.
[0045] "RNA transcript" refers to the product resulting from RNA
polymerase-catalyzed transcription of a DNA sequence. When the RNA
transcript is a perfect complementary copy of the DNA sequence, it
is referred to as the primary transcript or it may be a RNA
sequence derived from posttranscriptional processing of the primary
transcript and is referred to as the mature RNA. "Messenger RNA
(mRNA)" refers to the RNA that is without introns and that can be
translated into polypeptide by the cell. "cDNA" refers to a
double-stranded DNA that is complementary to and derived from mRNA.
"Sense" RNA refers to an RNA transcript that includes the mRNA and
so can be translated into a polypeptide by the cell. "Antisense
RNA" refers to an RNA transcript that is complementary to all or
part of a target primary transcript or mRNA and that blocks the
expression of a target gene (see U.S. Pat. No. 5,107,065,
incorporated herein by reference). The complementarity of an
antisense RNA may be with any part of the specific nucleotide
sequence, i.e., at the 5' non-coding sequence, 3' non-coding
sequence, introns, or the coding sequence. "Functional RNA" refers
to sense RNA, antisense RNA, ribozyme RNA, or other RNA that may
not be translated but yet has an effect on cellular processes.
[0046] The term "operably linked" refers to the association of two
or more nucleic acid fragments on a single nucleic acid fragment so
that the function of one is affected by the other. For example, a
promoter is operably linked with a coding sequence when it is
capable of affecting the expression of that coding sequence (i.e.,
that the coding sequence is under the transcriptional control of
the promoter). Coding sequences can be operably linked to
regulatory sequences in sense or antisense orientation.
[0047] The term "expression", as used herein, refers to the
transcription and stable accumulation of sense (mRNA) or antisense
RNA derived from the nucleic acid fragment of the invention.
Expression may also refer to translation of mRNA into a
polypeptide. "Antisense inhibition" refers to the production of
antisense RNA transcripts capable of suppressing the expression of
the target protein. "Overexpression" refers to the production of a
gene product in transgenic organisms that exceeds levels of
production in normal or non-transformed organisms. "Co-suppression"
refers to the production of sense RNA transcripts capable of
suppressing the expression of identical or substantially similar
foreign or endogenous genes (U.S. Pat. No. 5,231,020, incorporated
herein by reference).
[0048] "Altered levels" refers to the production of gene product(s)
in transgenic organisms in amounts or proportions that differ from
that of normal or non-transformed organisms.
[0049] "Mature" protein refers to a post-translationally processed
polypeptide; i.e., one from which any pre- or propeptides present
in the primary translation product have been removed. "Precursor"
protein refers to the primary product of translation of mRNA; i.e.,
with pre- and propeptides still present. Pre- and propeptides may
be but are not limited to intracellular localization signals.
[0050] A "chloroplast transit peptide" is an amino acid sequence
which is translated in conjunction with a protein and directs the
protein to the chloroplast or other plastid types present in the
cell in which the protein is made. "Chloroplast transit sequence"
refers to a nucleotide sequence that encodes a chloroplast transit
peptide. A "signal peptide" is an amino acid sequence which is
translated in conjunction with a protein and directs the protein to
the secretory system (Chrispeels (1991) Ann. Rev. Plant Phys. Plant
Mol. Biol. 42:21-53). If the protein is to be directed to a
vacuole, a vacuolar targeting signal (supra) can further be added,
or if to the endoplasmic reticulum, an endoplasmic reticulum
retention signal (supra) may be added. If the protein is to be
directed to the nucleus, any signal peptide present should be
removed and instead a nuclear localization signal included (Raikhel
(1992) Plant Phys. 100:1627-1632).
[0051] "Transformation" refers to the transfer of a nucleic acid
fragment into the genome of a host organism, resulting in
genetically stable inheritance. Host organisms containing the
transformed nucleic acid fragments are referred to as "transgenic"
organisms. Examples of methods of plant transformation include
Agrobacterium-mediated transformation (De Blaere et al. (1987)
Meth. Enzymol. 143:277) and particle-accelerated or "gene gun"
transformation technology (Klein et al. (1987) Nature (London)
327:70-73; U.S. Pat. No. 4,945,050, incorporated herein by
reference).
[0052] Standard recombinant DNA and molecular cloning techniques
used herein are well known in the art and are described more fully
in Sambrook et al. Molecular Cloning: A Laboratory Manual; Cold
Spring Harbor Laboratory Press: Cold Spring Harbor, 1989
(hereinafter "Maniatis").
[0053] Nucleic acid fragments encoding at least a portion of
several PDIs have been isolated and identified by comparison of
random plant cDNA sequences to public databases containing
nucleotide and protein sequences using the BLAST algorithms well
known to those skilled in the art. The nucleic acid fragments of
the instant invention may be used to isolate cDNAs and genes
encoding homologous proteins from the same or other plant species.
Isolation of homologous genes using sequence-dependent protocols is
well known in the art. Examples of sequence-dependent protocols
include, but are not limited to, methods of nucleic acid
hybridization, and methods of DNA and RNA amplification as
exemplified by various uses of nucleic acid amplification
technologies (e.g., polymerase chain reaction, ligase chain
reaction).
[0054] For example, genes encoding other PDIs, either as cDNAs or
genomic DNAs, could be isolated directly by using all or a portion
of the instant nucleic acid fragments as DNA hybridization probes
to screen libraries from any desired plant employing methodology
well known to those skilled in the art. Specific oligonucleotide
probes based upon the instant nucleic acid sequences can be
designed and synthesized by methods known in the art (Maniatis).
Moreover, the entire sequences can be used directly to synthesize
DNA probes by methods known to the skilled artisan such as random
primer DNA labeling, nick translation, or end-labeling techniques,
or RNA probes using available in vitro transcription systems. In
addition, specific primers can be designed and used to amplify a
part or all of the instant sequences. The resulting amplification
products can be labeled directly during amplification reactions or
labeled after amplification reactions, and used as probes to
isolate full length cDNA or genomic fragments under conditions of
appropriate stringency.
[0055] In addition, two short segments of the instant nucleic acid
fragments may be used in polymerase chain reaction protocols to
amplify longer nucleic acid fragments encoding homologous genes
from DNA or RNA. The polymerase chain reaction may also be
performed on a library of cloned nucleic acid fragments wherein the
sequence of one primer is derived from the instant nucleic acid
fragments, and the sequence of the other primer takes advantage of
the presence of the polyadenylic acid tracts to the 3' end of the
mRNA precursor encoding plant genes. Alternatively, the second
primer sequence may be based upon sequences derived from the
cloning vector. For example, the skilled artisan can follow the
RACE protocol (Frohman et al. (1988) Proc. Natl. Acad. Sci. USA
85:8998-9002) to generate cDNAs by using PCR to amplify copies of
the region between a single point in the transcript and the 3' or
5' end. Primers oriented in the 3' and 5' directions can be
designed from the instant sequences. Using commercially available
3' RACE or 5' RACE systems (BRL), specific 3' or 5' cDNA fragments
can be isolated (Ohara et al. (1989) Proc. Natl. Acad. Sci. USA
86:5673-5677; Loh et al. (1989) Science 243:217-220). Products
generated by the 3' and 5' RACE procedures can be combined to
generate full-length cDNAs (Frohman and Martin (1989) Techniques
1:165). Consequently, a polynucleotide comprising a nucleotide
sequence of at least one of 40 (preferably one of at least 30, most
preferably one of at least 15) contiguous nucleotides derived from
a nucleotide sequence selected from the group consisting of SEQ ID
NOs:1, 3, 5, 7, 9, 11, 13, 15, 17, 19 and the complement of such
nucleotide sequences may be used in such methods to obtain a
nucleic acid fragment encoding a substantial portion of an amino
acid sequence of a polypeptide (such as PDI precursor or PDI RB
60). The present invention relates to a method of obtaining a
nucleic acid fragment encoding a substantial portion of a
polypeptide of a gene (such as PDI precursor or PDI RB 60)
preferably a substantial portion of a polypeptide of a plant gene,
comprising the steps of: synthesizing an oligonucleotide primer
comprising a nucleotide sequence of at least one of 40 (preferably
at least one of 30, most preferably at least one of 15) contiguous
nucleotides derived from a nucleotide sequence selected from the
group consisting of SEQ ID NOs:1, 3, 5, 7, 9, 11, 13, 15, 17, 19
and the complement of such nucleotide sequences; and amplifying a
nucleic acid fragment (preferably a cDNA inserted in a cloning
vector) using the oligonucleotide primer. The amplified nucleic
acid fragment preferably will encode a portion of a polypeptide
(such as PDI precursor or PDI RB 60).
[0056] Availability of the instant nucleotide and deduced amino
acid sequences facilitates immunological screening of cDNA
expression libraries. Synthetic peptides representing portions of
the instant amino acid sequences may be synthesized. These peptides
can be used to immunize animals to produce polyclonal or monoclonal
antibodies with specificity for peptides or proteins comprising the
amino acid sequences. These antibodies can be then be used to
screen cDNA expression libraries to isolate full-length cDNA clones
of interest (Lerner (1984) Adv. Immunol. 36:1-34; Maniatis).
[0057] The nucleic acid fragments of the instant invention may be
used to create transgenic plants in which the disclosed
polypeptides are present at higher levels than normal or in cell
types or developmental stages in which they are not normally found.
This would have the effect of altering the level of properly folded
proteins in those cells. Coexpression of a member of the PDI family
with another foreign protein will result in a greater yield of
active, secreted foreign protein due to the improvement in proper
folding done by the PDI.
[0058] Overexpression of the proteins of the instant invention may
be accomplished by first constructing a chimeric gene in which the
coding region is operably linked to a promoter capable of directing
expression of a gene in the desired tissues at the desired stage of
development. For reasons of convenience, the chimeric gene may
comprise promoter sequences and translation leader sequences
derived from the same genes. 3' Non-coding sequences encoding
transcription termination signals may also be provided. The instant
chimeric gene may also comprise one or more introns in order to
facilitate gene expression.
[0059] Plasmid vectors comprising the instant chimeric gene can
then be constructed. The choice of plasmid vector is dependent upon
the method that will be used to transform host plants. The skilled
artisan is well aware of the genetic elements that must be present
on the plasmid vector in order to successfully transform, select
and propagate host cells containing the chimeric gene. The skilled
artisan will also recognize that different independent
transformation events will result in different levels and patterns
of expression (Jones et al. (1985) EMBO J. 4:2411-2418; De Almeida
et al. (1989) Mol. Gen. Genetics 218:78-86), and thus that multiple
events must be screened in order to obtain lines displaying the
desired expression level and pattern. Such screening may be
accomplished by Southern analysis of DNA, Northern analysis of mRNA
expression, Western analysis of protein expression, or phenotypic
analysis.
[0060] For some applications it may be useful to direct the instant
polypeptides to different cellular compartments, or to facilitate
its secretion from the cell. It is thus envisioned that the
chimeric gene described above may be further supplemented by
altering the coding sequence to encode the instant polypeptides
with appropriate intracellular targeting sequences such as transit
sequences (Keegstra (1989) Cell 56:247-253), signal sequences or
sequences encoding endoplasmic reticulum localization (Chrispeels
(1991) Ann. Rev. Plant Phys. Plant Mol. Biol. 42:21-53), or nuclear
localization signals (Raikhel (1992) Plant Phys. 100:1627-1632)
added and/or with targeting sequences that are already present
removed. While the references cited give examples of each of these,
the list is not exhaustive and more targeting signals of utility
may be discovered in the future.
[0061] The instant polypeptides (or portions thereof) may be
produced in heterologous host cells, particularly in the cells of
microbial hosts, and can be used to prepare antibodies to the these
proteins by methods well known to those skilled in the art. The
antibodies are useful for detecting the polypeptides of the instant
invention in situ in cells or in vitro in cell extracts. Preferred
heterologous host cells for production of the instant polypeptides
are microbial hosts. Microbial expression systems and expression
vectors containing regulatory sequences that direct high level
expression of foreign proteins are well known to those skilled in
the art. Any of these could be used to construct a chimeric gene
for production of the instant polypeptides. This chimeric gene
could then be introduced into appropriate microorganisms via
transformation to provide high level expression of the encoded
protein disulfide isomerases. An example of a vector for high level
expression of the instant polypeptides in a bacterial host is
provided (Example 7).
[0062] All or a substantial portion of the nucleic acid fragments
of the instant invention may also be used as probes for genetically
and physically mapping the genes that they are a part of, and as
markers for traits linked to those genes. Such information may be
useful in plant breeding in order to develop lines with desired
phenotypes. For example, the instant nucleic acid fragments may be
used as restriction fragment length polymorphism (RFLP) markers.
Southern blots (Maniatis) of restriction-digested plant genomic DNA
may be probed with the nucleic acid fragments of the instant
invention. The resulting banding patterns may then be subjected to
genetic analyses using computer programs such as MapMaker (Lander
et al. (1987) Genomics 1:174-181) in order to construct a genetic
map. In addition, the nucleic acid fragments of the instant
invention may be used to probe Southern blots containing
restriction endonuclease-treated genomic DNAs of a set of
individuals representing parent and progeny of a defined genetic
cross. Segregation of the DNA polymorphisms is noted and used to
calculate the position of the instant nucleic acid sequence in the
genetic map previously obtained using this population (Botstein et
al. (1980) Am. J. Hum. Genet. 32:314-331).
[0063] The production and use of plant gene-derived probes for use
in genetic mapping is described in Bernatzky and Tanksley (1986)
Plant Mol. Biol. Reporter 4:37-41. Numerous publications describe
genetic mapping of specific cDNA clones using the methodology
outlined above or variations thereof. For example, F2 intercross
populations, backcross populations, randomly mated populations,
near isogenic lines, and other sets of individuals may be used for
mapping. Such methodologies are well known to those skilled in the
art.
[0064] Nucleic acid probes derived from the instant nucleic acid
sequences may also be used for physical mapping (i.e., placement of
sequences on physical maps; see Hoheisel et al. In: Nonmammalian
Genomic Analysis: A Practical Guide, Academic press 1996, pp.
319-346, and references cited therein).
[0065] In another embodiment, nucleic acid probes derived from the
instant nucleic acid sequences may be used in direct fluorescence
in situ hybridization (FISH) mapping (Trask (1991) Trends Genet.
7:149-154). Although current methods of FISH mapping favor use of
large clones (several to several hundred KB; see Laan et al. (1995)
Genome Res. 5:13-20), improvements in sensitivity may allow
performance of FISH mapping using shorter probes.
[0066] A variety of nucleic acid amplification-based methods of
genetic and physical mapping may be carried out using the instant
nucleic acid sequences. Examples include allele-specific
amplification (Kazazian (1989) J. Lab. Clin. Med. 11:95-96),
polymorphism of PCR-amplified fragments (CAPS; Sheffield et al.
(1993) Genomics 16:325-332), allele-specific ligation (Landegren et
al. (1988) Science 241:1077-1080), nucleotide extension reactions
(Sokolov (1990) Nucleic Acid Res. 18:3671), Radiation Hybrid
Mapping (Walter et al. (1997) Nat. Genet. 7:22-28) and Happy
Mapping (Dear and Cook (1989) Nucleic Acid Res. 17:6795-6807). For
these methods, the sequence of a nucleic acid fragment is used to
design and produce primer pairs for use in the amplification
reaction or in primer extension reactions. The design of such
primers is well known to those skilled in the art. In methods
employing PCR-based genetic mapping, it may be necessary to
identify DNA sequence differences between the parents of the
mapping cross in the region corresponding to the instant nucleic
acid sequence. This, however, is generally not necessary for
mapping methods.
EXAMPLES
[0067] The present invention is further defined in the following
Examples, in which all parts and percentages are by weight and
degrees are Celsius, unless otherwise stated. It should be
understood that these Examples, while indicating preferred
embodiments of the invention, are given by way of illustration
only. From the above discussion and these Examples, one skilled in
the art can ascertain the essential characteristics of this
invention, and without departing from the spirit and scope thereof,
can make various changes and modifications of the invention to
adapt it to various usages and conditions.
Example 1
Composition of cDNA Libraries: Isolation and Sequencing of cDNA
Clones
[0068] cDNA libraries representing mRNAs from various balsam pear,
corn, rice, soybean and wheat tissues were prepared. The
characteristics of the libraries are described below.
2TABLE 2 cDNA Libraries from Balsam Pear, Corn, Rice, Soybean and
Wheat Library Tissue Clone cen3n Corn Endosperm 20 Days After
cen3n.pk0155.e7 Pollination* cr1n Corn Root From 7 Day Old
Seedlings* cr1n.pk0090.d2 cs1 Corn Leaf Sheath From 5 Week Old
Plant cs1.pk0077.f10 cs1 Corn Leaf Sheath From 5 Week Old Plant
cs1.pk0100.a7 csi1 Corn Silk csi1.pk0032.c9 fds Momordica charantia
Developing Seed fds.pk0022.c11 p0032 Corn Regenerating Callus
p0032.crcbb52r (Hi-II 223a and 1129e), 10 and 14 Days After Auxin
Removal, Pooled p0125 Corn Anther Prophase I* p0125.czabp07r scr1c
Soybean Embryogenic Suspension Culture scr1c.pk005.i17 Subjected to
4 Vacuum Cycles and Collected 12 Hours Later sdp2c Soybean
Developing Pods (6-7 mm) sdp2c.pk038.e22 sdp3c Soybean Developing
Pods (8-9 mm) sdp3c.pk021.a3 sfl1 Soybean Immature Flower
sfl1.pk0026.h1 sl2 Soybean Two-Week-Old Developing sl2.pk0075.b10
Seedlings Treated With 2.5 ppm chlorimuron sr1 Soybean Root
sr1.pk0095.e9 srr3c Soybean 8-Day-Old Root srr3c.pk002.a8 wl1n
Wheat Leaf From 7 Day Old Seedling* wl1n.pk0027.f4 wre1n Wheat Root
From 7 Day Old wre1n.pk0015.d10 Etiolated Seedling* *These
libraries were normalized essentially as described in U.S. Pat. No.
5,482,845, incorporated herein by reference.
[0069] cDNA libraries may be prepared by any one of many methods
available. For example, the cDNAs may be introduced into plasmid
vectors by first preparing the cDNA libraries in Uni-ZAP.TM. XR
vectors according to the manufacturer's protocol (Stratagene
Cloning Systems, La Jolla, Calif.). The Uni-ZAP.TM. XR libraries
are converted into plasmid libraries according to the protocol
provided by Stratagene. Upon conversion, cDNA inserts will be
contained in the plasmid vector pBluescript. In addition, the cDNAs
may be introduced directly into precut Bluescript II SK(+) vectors
(Stratagene) using T4 DNA ligase (New England Biolabs), followed by
transfection into DH10B cells according to the manufacturer's
protocol (GIBCO BRL Products). Once the cDNA inserts are in plasmid
vectors, plasmid DNAs are prepared from randomly picked bacterial
colonies containing recombinant pBluescript plasmids, or the insert
cDNA sequences are amplified via polymerase chain reaction using
primers specific for vector sequences flanking the inserted cDNA
sequences. Amplified insert DNAs or plasmid DNAs are sequenced in
dye-primer sequencing reactions to generate partial cDNA sequences
(expressed sequence tags or "ESTs"; see Adams et al., (1991)
Science 252:1651-1656). The resulting ESTs are analyzed using a
Perkin Elmer Model 377 fluorescent sequencer.
Example 2
Identification of cDNA Clones
[0070] cDNA clones encoding protein disulfide isomerases were
identified by conducting BLAST (Basic Local Alignment Search Tool;
Altschul et al. (1993) J. Mol. Biol. 215:403-410; see also
www.ncbi.nlm.nih.gov/BLAST/) searches for similarity to sequences
contained in the BLAST "nr" database (comprising all non-redundant
GenBank CDS translations, sequences derived from the 3-dimensional
structure Brookhaven Protein Data Bank, the last major release of
the SWISS-PROT protein sequence database, EMBL, and DDBJ
databases). The cDNA sequences obtained in Example 1 were analyzed
for similarity to all publicly available DNA sequences contained in
the "nr" database using the BLASTN algorithm provided by the
National Center for Biotechnology Information (NCBI). The DNA
sequences were translated in all reading frames and compared for
similarity to all publicly available protein sequences contained in
the "nr" database using the BLASTX algorithm (Gish and States
(1993) Nat. Genet. 3:266-272) provided by the NCBI. For
convenience, the P-value (probability) of observing a match of a
cDNA sequence to a sequence contained in the searched databases
merely by chance as calculated by BLAST are reported herein as
"pLog" values, which represent the negative of the logarithm of the
reported P-value. Accordingly, the greater the pLog value, the
greater the likelihood that the cDNA sequence and the BLAST "hit"
represent homologous proteins.
Example 3
Characterization of cDNA Clones Encoding Protein Disulfide
Isomerase Precursor
[0071] The BLASTX search using the EST sequences from clones listed
in Table 3 revealed similarity of the polypeptides encoded by the
cDNAs to protein disulfide isomerase precursor from Humicola
insolens or Bos taurus (NCBI General Identifier Nos. 1709618 and
129726, respectively). Shown in Table 3 are the BLAST results for
individual ESTs ("EST"), or the sequences of the entire cDNA
inserts comprising the indicated cDNA clones ("FIS"):
3TABLE 3 BLAST Results for Sequences Encoding Polypeptides
Homologous to Protein Disulfide Isomerase Precursor NCBI General
BLAST Clone Status Identifier No. pLog Score cr1n.pk0090.d2 EST
1709618 55.52 srr3c.pk002.a8 EST 1709618 48.52 csi1.pk0032.c9:fis
FIS 129726 28.04
[0072] The data in Table 4 represents a calculation of the percent
identity of the amino acid sequences set forth in SEQ ID NOs:2, 4
and 6 and the Humicola insolens and Bos taurus sequences (NCBI
General Identifier Nos. 1709618 and 129726, respectively).
4TABLE 4 Percent Identity of Amino Acid Sequences Deduced From the
Nucleotide Sequences of cDNA Clones Encoding Polypeptides
Homologous to Protein Disulfide Isomerase Precursor Percent
Identity to SEQ ID NO. 1709618 129726 2 80.0 42.7 4 17.0 22.2 6
50.0 37.3
[0073] Sequence alignments and percent identity calculations were
performed using the Megalign program of the LASERGENE
bioinformatics computing suite (DNASTAR Inc., Madison, Wis.).
Multiple alignment of the sequences was performed using the Clustal
method of alignment (Higgins and Sharp (1989) CABIOS. 5:151-153)
with the default parameters (GAP PENALTY=10, GAP LENGTH
PENALTY=10). Default parameters for pairwise alignments using the
Clustal method were KTUPLE 1, GAP PENALTY=3, WINDOW=5 and DIAGONALS
SAVED=5. Sequence alignments and BLAST scores and probabilities
indicate that the nucleic acid fragments comprising the instant
cDNA clones encode a substantial portion of two corn and one
soybean protein disulfide isomerase precursor. These sequences
represent the first corn and soybean sequences encoding protein
disulfide isomerase precursor.
Example 4
Characterization of cDNA Clones Encoding RB60
[0074] The BLASTX search using the EST sequences from clones listed
in Table 5 revealed similarity of the polypeptides encoded by the
cDNAs to RB60 from Chlamydomonas reinhardtii and to the putative
protein disulfide isomerase-like protein from Arabidopsis thaliana
resulting from the EU Arabidopsis sequencing project (NCBI General
Identifier Nos. 2708314 and 4678297, respectively). Shown in Table
5 are the BLAST results for individual ESTs ("EST"), the sequences
of the entire cDNA inserts comprising the indicated cDNA clones
("FIS"), or contigs assembled from an FIS and one or more ESTs
("Contig*"):
5TABLE 5 BLAST Results for Sequences Encoding Polypeptides
Homologousto RB60 BLAST pLog Score Clone Status 2708314 4678297
fds.pk0022.c11 FIS 101.00 >254.00 Contig of: Contig* 95.00
157.00 cen3n.pk0155.e7 cs1.pk0100.a7 p0032.crcbb52r p0125.czabp07r
cs1.pk0077.f10 FIS 47.15 83.52 sr1.pk0095.e9 FIS 34.30 31.70 Contig
of: Contig* 105.00 >254.00 scr1c.pk005.i17 sdp2c.pk038.e22
sdp3c.pk021.a3 sfl1.pk0026.h1 sl2.pk0075.b10 wl1n.pk0027.f4 EST
58.30 59.09 wre1n.pk0015.d10 FIS 59.00 92.00
[0075] The sequences from clones wl1n.pk0027.f4 and sr1l.pk0095.e9
also showed similarity to the predicted gene encoded by the contig
of the rice ESTs D22477 and AU75323. The data in Table 6 represents
a calculation of the percent identity of the amino acid sequences
set forth in SEQ ID NOs:8, 10, 12, 14, 16, 18 and 20 and the
Chlamydomonas reinhardtii and Arabidopsis thaliana sequences (NCBI
General Identifier Nos. 2708314 and 4678297).
6TABLE 4 Percent Identity of Amino Acid Sequences Deduced From the
Nucleotide Sequences of cDNA Clones Encoding Polypeptides
Homologous to RB60 Percent Identity to SEQ ID NO. 2708314 4678297 8
35.5 58.8 10 32.0 47.9 12 39.5 66.4 14 28.3 25.9 16 34.8 57.0 18
27.3 25.9 20 35.4 53.4
[0076] Sequence alignments and percent identity calculations were
performed using the Megalign program of the LASERGENE
bioinformatics computing suite (DNASTAR Inc., Madison, Wis.).
Multiple alignment of the sequences was performed using the Clustal
method of alignment (Higgins and Sharp (1989) CABIOS. 5:151-153)
with the default parameters (GAP PENALTY=10, GAP LENGTH
PENALTY=10). Default parameters for pairwise alignments using the
Clustal method were KTUPLE 1, GAP PENALTY=3, WINDOW=5 and DIAGONALS
SAVED=5. Sequence alignments and BLAST scores and probabilities
indicate that the nucleic acid fragments comprising the instant
cDNA clones encode a substantial portion of a balsam pear, two
corn, two soybean and two wheat RB60. These sequences represent the
first balsam pear, corn, soybean and wheat sequences encoding
RB60.
Example 5
Expression of Chimeric Genes in Monocot Cells
[0077] A chimeric gene comprising a cDNA encoding the instant
polypeptides in sense orientation with respect to the maize 27 kD
zein promoter that is located 5' to the cDNA fragment, and the 10
kD zein 3' end that is located 3' to the cDNA fragment, can be
constructed. The cDNA fragment of this gene may be generated by
polymerase chain reaction (PCR) of the cDNA clone using appropriate
oligonucleotide primers. Cloning sites (NcoI or SmaI) can be
incorporated into the oligonucleotides to provide proper
orientation of the DNA fragment when inserted into the digested
vector pML103 as described below. Amplification is then performed
in a standard PCR. The amplified DNA is then digested with
restriction enzymes NcoI and SmaI and fractionated on an agarose
gel. The appropriate band can be isolated from the gel and combined
with a 4.9 kb NcoI-SmaI fragment of the plasmid pML103. Plasmid
pML103 has been deposited under the terms of the Budapest Treaty at
ATCC (American Type Culture Collection, 10801 University Blvd.,
Manassas, Va. 20110-2209), and bears accession number ATCC 97366.
The DNA segment from pML103 contains a 1.05 kb SalI-NcoI promoter
fragment of the maize 27 kD zein gene and a 0.96 kb SmaI-SalI
fragment from the 3' end of the maize 10 kD zein gene in the vector
pGem9Zf(+) (Promega). Vector and insert DNA can be ligated at
15.degree. C. overnight, essentially as described (Maniatis). The
ligated DNA may then be used to transform E. coli XL1-Blue
(Epicurian Coli XL-1 Blue.TM.; Stratagene). Bacterial transformants
can be screened by restriction enzyme digestion of plasmid DNA and
limited nucleotide sequence analysis using the dideoxy chain
termination method (Sequenase.TM. DNA Sequencing Kit; U.S.
Biochemical). The resulting plasmid construct would comprise a
chimeric gene encoding, in the 5' to 3' direction, the maize 27 kD
zein promoter, a cDNA fragment encoding the instant polypeptides,
and the 10 kD zein 3' region.
[0078] The chimeric gene described above can then be introduced
into corn cells by the following procedure. Immature corn embryos
can be dissected from developing caryopses derived from crosses of
the inbred corn lines H99 and LH132. The embryos are isolated 10 to
11 days after pollination when they are 1.0 to 1.5 mm long. The
embryos are then placed with the axis-side facing down and in
contact with agarose-solidified N6 medium (Chu et al. (1975) Sci.
Sin. Peking 18:659-668). The embryos are kept in the dark at
27.degree. C. Friable embryogenic callus consisting of
undifferentiated masses of cells with somatic proembryoids and
embryoids borne on suspensor structures proliferates from the
scutellum of these immature embryos. The embryogenic callus
isolated from the primary explant can be cultured on N6 medium and
sub-cultured on this medium every 2 to 3 weeks.
[0079] The plasmid, p35S/Ac (obtained from Dr. Peter Eckes, Hoechst
Ag, Frankfurt, Germany) may be used in transformation experiments
in order to provide for a selectable marker. This plasmid contains
the Pat gene (see European Patent Publication 0 242 236) which
encodes phosphinothricin acetyl transferase (PAT). The enzyme PAT
confers resistance to herbicidal glutamine synthetase inhibitors
such as phosphinothricin. The pat gene in p35S/Ac is under the
control of the 35S promoter from Cauliflower Mosaic Virus (Odell et
al. (1985) Nature 313:810-812) and the 3' region of the nopaline
synthase gene from the T-DNA of the Ti plasmid of Agrobacterium
tumefaciens.
[0080] The particle bombardment method (Klein et al. (1987) Nature
327:70-73) may be used to transfer genes to the callus culture
cells. According to this method, gold particles (1 .mu.m in
diameter) are coated with DNA using the following technique. Ten
.mu.g of plasmid DNAs are added to 50 .mu.L of a suspension of gold
particles (60 mg per mL). Calcium chloride (50 .mu.L of a 2.5 M
solution) and spermidine free base (20 .mu.L of a 1.0 M solution)
are added to the particles. The suspension is vortexed during the
addition of these solutions. After 10 minutes, the tubes are
briefly centrifuged (5 sec at 15,000 rpm) and the supernatant
removed. The particles are resuspended in 200 .mu.L of absolute
ethanol, centrifuged again and the supernatant removed. The ethanol
rinse is performed again and the particles resuspended in a final
volume of 30 .mu.L of ethanol. An aliquot (5 .mu.L) of the
DNA-coated gold particles can be placed in the center of a
Kapton.TM. flying disc (Bio-Rad Labs). The particles are then
accelerated into the corn tissue with a Biolistic.TM. PDS-1000/He
(Bio-Rad Instruments, Hercules Calif.), using a helium pressure of
1000 psi, a gap distance of 0.5 cm and a flying distance of 1.0
cm.
[0081] For bombardment, the embryogenic tissue is placed on filter
paper over agarose-solidified N6 medium. The tissue is arranged as
a thin lawn and covered a circular area of about 5 cm in diameter.
The petri dish containing the tissue can be placed in the chamber
of the PDS-1000/He approximately 8 cm from the stopping screen. The
air in the chamber is then evacuated to a vacuum of 28 inches of
Hg. The macrocarrier is accelerated with a helium shock wave using
a rupture membrane that bursts when the He pressure in the shock
tube reaches 1000 psi.
[0082] Seven days after bombardment the tissue can be transferred
to N6 medium that contains gluphosinate (2 mg per liter) and lacks
casein or proline. The tissue continues to grow slowly on this
medium. After an additional 2 weeks the tissue can be transferred
to fresh N6 medium containing gluphosinate. After 6 weeks, areas of
about 1 cm in diameter of actively growing callus can be identified
on some of the plates containing the glufosinate-supplemented
medium. These calli may continue to grow when sub-cultured on the
selective medium.
[0083] Plants can be regenerated from the transgenic callus by
first transferring clusters of tissue to N6 medium supplemented
with 0.2 mg per liter of 2,4-D. After two weeks the tissue can be
transferred to regeneration medium (Fromm et al. (1990)
Bio/Technology 8:833-839).
Example 6
Expression of Chimeric Genes in Dicot Cells
[0084] A seed-specific expression cassette composed of the promoter
and transcription terminator from the gene encoding the .beta.
subunit of the seed storage protein phaseolin from the bean
Phaseolus vulgaris (Doyle et al. (1986) J. Biol. Chem.
261:9228-9238) can be used for expression of the instant
polypeptides in transformed soybean. The phaseolin cassette
includes about 500 nucleotides upstream (5') from the translation
initiation codon and about 1650 nucleotides downstream (3') from
the translation stop codon of phaseolin. Between the 5' and 3'
regions are the unique restriction endonuclease sites Nco I (which
includes the ATG translation initiation codon), Sma I, Kpn I and
Xba I. The entire cassette is flanked by Hind III sites.
[0085] The cDNA fragment of this gene may be generated by
polymerase chain reaction (PCR) of the cDNA clone using appropriate
oligonucleotide primers. Cloning sites can be incorporated into the
oligonucleotides to provide proper orientation of the DNA fragment
when inserted into the expression vector. Amplification is then
performed as described above, and the isolated fragment is inserted
into a pUC18 vector carrying the seed expression cassette.
[0086] Soybean embroys may then be transformed with the expression
vector comprising sequences encoding the instant polypeptides. To
induce somatic embryos, cotyledons, 3-5 mm in length dissected from
surface sterilized, immature seeds of the soybean cultivar A2872,
can be cultured in the light or dark at 26.degree. C. on an
appropriate agar medium for 6-10 weeks. Somatic embryos which
produce secondary embryos are then excised and placed into a
suitable liquid medium. After repeated selection for clusters of
somatic embryos which multiplied as early, globular staged embryos,
the suspensions are maintained as described below.
[0087] Soybean embryogenic suspension cultures can maintained in 35
mL liquid media on a rotary shaker, 150 rpm, at 26.degree. C. with
florescent lights on a 16:8 hour day/night schedule. Cultures are
subcultured every two weeks by inoculating approximately 35 mg of
tissue into 35 mL of liquid medium.
[0088] Soybean embryogenic suspension cultures may then be
transformed by the method of particle gun bombardment (Klein et al.
(1987) Nature (London) 327:70-73, U.S. Pat. No. 4,945,050). A
DuPont Biolistic.TM. PDS1000/HE instrument (helium retrofit) can be
used for these transformations.
[0089] A selectable marker gene which can be used to facilitate
soybean transformation is a chimeric gene composed of the 35S
promoter from Cauliflower Mosaic Virus (Odell et al. (1985) Nature
313:810-812), the hygromycin phosphotransferase gene from plasmid
pJR225 (from E. coli; Gritz et al.(1983) Gene 25:179-188) and the
3' region of the nopaline synthase gene from the T-DNA of the Ti
plasmid of Agrobacterium tumefaciens. The seed expression cassette
comprising the phaseolin 5' region, the fragment encoding the
instant polypeptides and the phaseolin 3' region can be isolated as
a restriction fragment. This fragment can then be inserted into a
unique restriction site of the vector carrying the marker gene.
[0090] To 50 .mu.L of a 60 mg/mL 1 .mu.m gold particle suspension
is added (in order): 5 .mu.L DNA (1 .mu.g/.mu.L), 20 .mu.l
spermidine (0.1 M), and 50 .mu.L CaCl.sub.2 (2.5 M). The particle
preparation is then agitated for three minutes, spun in a microfuge
for 10 seconds and the supernatant removed. The DNA-coated
particles are then washed once in 400 .mu.L 70% ethanol and
resuspended in 40 .mu.L of anhydrous ethanol. The DNA/particle
suspension can be sonicated three times for one second each. Five
.mu.L of the DNA-coated gold particles are then loaded on each
macro carrier disk.
[0091] Approximately 300-400 mg of a two-week-old suspension
culture is placed in an empty 60.times.15 mm petri dish and the
residual liquid removed from the tissue with a pipette. For each
transformation experiment, approximately 5-10 plates of tissue are
normally bombarded. Membrane rupture pressure is set at 1100 psi
and the chamber is evacuated to a vacuum of 28 inches mercury. The
tissue is placed approximately 3.5 inches away from the retaining
screen and bombarded three times. Following bombardment, the tissue
can be divided in half and placed back into liquid and cultured as
described above.
[0092] Five to seven days post bombardment, the liquid media may be
exchanged with fresh media, and eleven to twelve days post
bombardment with fresh media containing 50 mg/mL hygromycin. This
selective media can be refreshed weekly. Seven to eight weeks post
bombardment, green, transformed tissue may be observed growing from
untransformed, necrotic embryogenic clusters. Isolated green tissue
is removed and inoculated into individual flasks to generate new,
clonally propagated, transformed embryogenic suspension cultures.
Each new line may be treated as an independent transformation
event. These suspensions can then be subcultured and maintained as
clusters of immature embryos or regenerated into whole plants by
maturation and germination of individual somatic embryos.
Example 7
Expression of Chimeric Genes in Microbial Cells
[0093] The cDNAs encoding the instant polypeptides can be inserted
into the T7 E. coli expression vector pBT430. This vector is a
derivative of pET-3a (Rosenberg et al. (1987) Gene 56:125-135)
which employs the bacteriophage T7 RNA polymerase/T7 promoter
system. Plasmid pBT430 was constructed by first destroying the EcoR
I and Hind III sites in pET-3a at their original positions. An
oligonucleotide adaptor containing EcoR I and Hind III sites was
inserted at the BamH I site of pET-3a. This created pET-3aM with
additional unique cloning sites for insertion of genes into the
expression vector. Then, the Nde I site at the position of
translation initiation was converted to an Nco I site using
oligonucleotide-directed mutagenesis. The DNA sequence of pET-3aM
in this region, 5'-CATATGG, was converted to 5'-CCCATGG in
pBT430.
[0094] Plasmid DNA containing a cDNA may be appropriately digested
to release a nucleic acid fragment encoding the protein. This
fragment may then be purified on a 1% NuSieve GTG.TM. low melting
agarose gel (FMC). Buffer and agarose contain 10 .mu.g/ml ethidium
bromide for visualization of the DNA fragment. The fragment can
then be purified from the agarose gel by digestion with GELase.TM.
(Epicentre Technologies) according to the manufacturer's
instructions, ethanol precipitated, dried and resuspended in 20
.mu.L of water. Appropriate oligonucleotide adapters may be ligated
to the fragment using T4 DNA ligase (New England Biolabs, Beverly,
Mass.). The fragment containing the ligated adapters can be
purified from the excess adapters using low melting agarose as
described above. The vector pBT430 is digested, dephosphorylated
with alkaline phosphatase (NEB) and deproteinized with
phenol/chloroform as described above. The prepared vector pBT430
and fragment can then be ligated at 16.degree. C. for 15 hours
followed by transformation into DH5 electrocompetent cells (GIBCO
BRL). Transformants can be selected on agar plates containing LB
media and 100 .mu.g/mL ampicillin. Transformants containing the
gene encoding the instant polypeptides are then screened for the
correct orientation with respect to the T7 promoter by restriction
enzyme analysis.
[0095] For high level expression, a plasmid clone with the cDNA
insert in the correct orientation relative to the T7 promoter can
be transformed into E. coli strain BL21(DE3) (Studier et al. (1986)
J. Mol. Biol. 189:113-130). Cultures are grown in LB medium
containing ampicillin (100 mg/L) at 25.degree. C. At an optical
density at 600 nm of approximately 1, IPTG
(isopropylthio-.beta.-galactoside, the inducer) can be added to a
final concentration of 0.4 mM and incubation can be continued for 3
h at 25.degree.. Cells are then harvested by centrifugation and
re-suspended in 50 .mu.L of 50 mM Tris-HCl at pH 8.0 containing 0.1
mM DTT and 0.2 mM phenyl methylsulfonyl fluoride. A small amount of
1 mm glass beads can be added and the mixture sonicated 3 times for
about 5 seconds each time with a microprobe sonicator. The mixture
is centrifuged and the protein concentration of the supernatant
determined. One .mu.g of protein from the soluble fraction of the
culture can be separated by SDS-polyacrylamide gel electrophoresis.
Gels can be observed for protein bands migrating at the expected
molecular weight.
Sequence CWU 1
1
20 1 504 DNA Zea mays unsure (463) n is a, c, g or t 1 tgcctgccct
gtcctgtcct gttcagcgga accttctctt tgtgttttat aggttacccc 60
gtcaaaaaga cagcccatca tgcaccacaa gaagatcgcc tgcagcttca tggctgctct
120 ggctgcctat gcctctgctg ccgactcaga tgttcatcag ctaaccaagg
acaccttcga 180 ggagtttgtc aagtccaaca atctcgtcct cgctgagttc
tttgctccct ggtgcggtca 240 ctgcaaggcc ctcgcccccg agtacgagga
ggccgccaca actctcaagg agaagaacat 300 caagcttgcc aagattgact
gcactgagga gtccgacctc tgcaaagacc agggcgtcga 360 gggttacccc
accctcaagg tcttccgtgg tcttgacaat gtcactccct actctggcca 420
gcgtaaggcc gctggtatca ttctacatga ttaagagttc ctncccggng nttcatttta
480 caaagggaac cctcgngggt ttaa 504 2 110 PRT Zea mays 2 Met Ala Ala
Leu Ala Ala Tyr Ala Ser Ala Ala Asp Ser Asp Val His 1 5 10 15 Gln
Leu Thr Lys Asp Thr Phe Glu Glu Phe Val Lys Ser Asn Asn Leu 20 25
30 Val Leu Ala Glu Phe Phe Ala Pro Trp Cys Gly His Cys Lys Ala Leu
35 40 45 Ala Pro Glu Tyr Glu Glu Ala Ala Thr Thr Leu Lys Glu Lys
Asn Ile 50 55 60 Lys Leu Ala Lys Ile Asp Cys Thr Glu Glu Ser Asp
Leu Cys Lys Asp 65 70 75 80 Gln Gly Val Glu Gly Tyr Pro Thr Leu Lys
Val Phe Arg Gly Leu Asp 85 90 95 Asn Val Thr Pro Tyr Ser Gly Gln
Arg Lys Ala Ala Gly Ile 100 105 110 3 505 DNA Glycine max unsure
(503) n is a, c, g or t 3 tctttctggt actccacctg gtattgttgt
tgaagatcgt aataccaata aaaattatgt 60 ttatccacaa gctaatgaaa
ttactgaaga tgcattacgt gcacatttac aaggttatgt 120 tgatggtaca
cttcaaccca ctgtcaaatc tgaagaaatc ccagaaaaac aagatggtcc 180
agtttatgta ctcgtgggta aaaattttga atccattgtt atggatgaaa ctaaagatgt
240 attagttgaa ttttatgcac catggtgtgg acattgtaaa acattagctc
ccaaatacga 300 tgcattaggt gaatcattca agtcaaaccc caatgtcatt
attgccaaga ttgatgccac 360 tgcaaatgat acccctgttg atattcaagg
tttccccact attatctatt ggccagctaa 420 taataagaaa aatccaatta
catatgaagg tgaacgtact gaatcagcac ttgctgcatt 480 tgtacgtgaa
aaatggtcaa cantt 505 4 158 PRT Glycine max 4 Pro Gly Ile Val Val
Glu Asp Arg Asn Thr Asn Lys Asn Tyr Val Tyr 1 5 10 15 Pro Gln Ala
Asn Glu Ile Thr Glu Asp Ala Leu Arg Ala His Leu Gln 20 25 30 Gly
Tyr Val Asp Gly Thr Leu Gln Pro Thr Val Lys Ser Glu Glu Ile 35 40
45 Pro Glu Lys Gln Asp Gly Pro Val Tyr Val Leu Val Gly Lys Asn Phe
50 55 60 Glu Ser Ile Val Met Asp Glu Thr Lys Asp Val Leu Val Glu
Phe Tyr 65 70 75 80 Ala Pro Trp Cys Gly His Cys Lys Thr Leu Ala Pro
Lys Tyr Asp Ala 85 90 95 Leu Gly Glu Ser Phe Lys Ser Asn Pro Asn
Val Ile Ile Ala Lys Ile 100 105 110 Asp Ala Thr Ala Asn Asp Thr Pro
Val Asp Ile Gln Gly Phe Pro Thr 115 120 125 Ile Ile Tyr Trp Pro Ala
Asn Asn Lys Lys Asn Pro Ile Thr Tyr Glu 130 135 140 Gly Glu Arg Thr
Glu Ser Ala Leu Ala Ala Phe Val Arg Glu 145 150 155 5 1692 DNA Zea
mays 5 gcacgaggcg cggcggagat cgaatcgagc gcccgccacg gcgatggcga
ctagagtcct 60 gccgccggct ctgctctctt tcatactcct cctgctgctc
tcgctctcag cccgcgacac 120 cgtcgccgcg ggcgaggatt tcccacgcga
cgggcgggtg atcgacctcg acgacagcaa 180 tttcgaggcg gcgctgggcg
ccatcgactt tctcttcgtc gacttctacg ccccttggtg 240 cggccactgc
aagagacttg cgcccgagtt agatgaagct gcaccggtgt tgtcagggtt 300
gagtgagcct attgttgttg ccaaagtcaa cgctgataaa tacagaaaac tcggatcaaa
360 atatggagtg gatgggttcc ctaccctcat gctctttatc catggtgttc
caattgaata 420 cactggttcg aggaaagctg accagcttgt ccgcaatctg
aagaagttcg tttcgccaga 480 tgtttctatc cttgagtcag attctgcgat
aaagaacttt gttgagaatg ctgggataag 540 ctttccgata ttccttggtt
ttggggtgaa tgactcattg attgctgagt atggaaggaa 600 atacaagaaa
agagcctggt ttgctgttgc taaagatttc tctgaggaca tcatggtagc 660
ctatgaattt gataaggttc cagcactagt tgctatccat ccaaagtata aggaacagag
720 tttgttctat ggcccatttg aagaaaattt cttagaagat tttgtacggc
aatcccttct 780 ccctttggtt gtcccaatca atacagagac actaaaaatg
ctgaatgatg atcagaggaa 840 agttgttctc acaattttgg aggatgattc
agatgaaaac tctacgcaac tggtaaagat 900 tttgcgatct gctgctaatg
caaaccgtga tttggtgttt ggatatgttg gaatcaagca 960 atgggatggg
tttgtggaga cttttgatgt ttccaagagc tcacagctgc caaagctact 1020
tgtgtgggat agagatgagg agtatgagct agtggatggt tcagagagat tagaagaagg
1080 tgaccaagca tctcaaataa gccaattcct tgagggatac agagcaggaa
gaacaacaaa 1140 gaagaaaatc accggccctt ctttcatggg tttcctgaac
tctctggtca gcctgaactc 1200 gctgtacatc cttatatttg tcatcgccct
tctgtttgtc atggtgtact ttgctgggca 1260 agatgatact cctcagccaa
gacgaattca cgaagagtga tgaaagcttg ttgggcttct 1320 tgcacctaaa
gatggctaat ctaccgggag attagctttt gtattaattg tacaaaagct 1380
tcaactgacg caagtcgtga agagtggttt tggcaatttg gccattcatg ctgagtttct
1440 tcaatctcta ttggcgacat caatttctgc atcctgccta tttgtgtttc
tgctttgtgc 1500 ccttcaattt gttctttaat ttagagctta gaaattagcc
tctgcctgtg tattctggaa 1560 cctgccattc cagagtccat ttctgtgaaa
atatatttat tattatcata ctctgctacc 1620 gagcttttgt acaattaata
caggatatat agactgttct ggtgcacaaa aaaaaaaaga 1680 aaaaaaaaaa aa 1692
6 418 PRT Zea mays 6 Met Ala Thr Arg Val Leu Pro Pro Ala Leu Leu
Ser Phe Ile Leu Leu 1 5 10 15 Leu Leu Leu Ser Leu Ser Ala Arg Asp
Thr Val Ala Ala Gly Glu Asp 20 25 30 Phe Pro Arg Asp Gly Arg Val
Ile Asp Leu Asp Asp Ser Asn Phe Glu 35 40 45 Ala Ala Leu Gly Ala
Ile Asp Phe Leu Phe Val Asp Phe Tyr Ala Pro 50 55 60 Trp Cys Gly
His Cys Lys Arg Leu Ala Pro Glu Leu Asp Glu Ala Ala 65 70 75 80 Pro
Val Leu Ser Gly Leu Ser Glu Pro Ile Val Val Ala Lys Val Asn 85 90
95 Ala Asp Lys Tyr Arg Lys Leu Gly Ser Lys Tyr Gly Val Asp Gly Phe
100 105 110 Pro Thr Leu Met Leu Phe Ile His Gly Val Pro Ile Glu Tyr
Thr Gly 115 120 125 Ser Arg Lys Ala Asp Gln Leu Val Arg Asn Leu Lys
Lys Phe Val Ser 130 135 140 Pro Asp Val Ser Ile Leu Glu Ser Asp Ser
Ala Ile Lys Asn Phe Val 145 150 155 160 Glu Asn Ala Gly Ile Ser Phe
Pro Ile Phe Leu Gly Phe Gly Val Asn 165 170 175 Asp Ser Leu Ile Ala
Glu Tyr Gly Arg Lys Tyr Lys Lys Arg Ala Trp 180 185 190 Phe Ala Val
Ala Lys Asp Phe Ser Glu Asp Ile Met Val Ala Tyr Glu 195 200 205 Phe
Asp Lys Val Pro Ala Leu Val Ala Ile His Pro Lys Tyr Lys Glu 210 215
220 Gln Ser Leu Phe Tyr Gly Pro Phe Glu Glu Asn Phe Leu Glu Asp Phe
225 230 235 240 Val Arg Gln Ser Leu Leu Pro Leu Val Val Pro Ile Asn
Thr Glu Thr 245 250 255 Leu Lys Met Leu Asn Asp Asp Gln Arg Lys Val
Val Leu Thr Ile Leu 260 265 270 Glu Asp Asp Ser Asp Glu Asn Ser Thr
Gln Leu Val Lys Ile Leu Arg 275 280 285 Ser Ala Ala Asn Ala Asn Arg
Asp Leu Val Phe Gly Tyr Val Gly Ile 290 295 300 Lys Gln Trp Asp Gly
Phe Val Glu Thr Phe Asp Val Ser Lys Ser Ser 305 310 315 320 Gln Leu
Pro Lys Leu Leu Val Trp Asp Arg Asp Glu Glu Tyr Glu Leu 325 330 335
Val Asp Gly Ser Glu Arg Leu Glu Glu Gly Asp Gln Ala Ser Gln Ile 340
345 350 Ser Gln Phe Leu Glu Gly Tyr Arg Ala Gly Arg Thr Thr Lys Lys
Lys 355 360 365 Ile Thr Gly Pro Ser Phe Met Gly Phe Leu Asn Ser Leu
Val Ser Leu 370 375 380 Asn Ser Leu Tyr Ile Leu Ile Phe Val Ile Ala
Leu Leu Phe Val Met 385 390 395 400 Val Tyr Phe Ala Gly Gln Asp Asp
Thr Pro Gln Pro Arg Arg Ile His 405 410 415 Glu Glu 7 1774 DNA
Momordica charantia 7 gcacgaggag ccggatgcgg cggccggtgc ttccgctcat
cgtcacctcc ccgactttga 60 tggttttgag ggaggtgccg aggacgagga
ttttggggac ttctccgatt ttgaggactc 120 ggatgctgat cgggatgagt
acaaggcgcc ggaggtggac gagaaggatg tcgtcgtgtt 180 gaaggagggt
aacttcagcg atttcgtgga gaagaaccgg tttgttatgg tggagtttta 240
cgctccctgg tgtggtcact gccaggcgct ggcgccggag tatgctgctg ccgccactga
300 attgaaaggc gagaacgtgg ttttggcgaa ggttgatgcg acggaggaga
atgaattgtc 360 gcagaagtac gacgttcaag gatttccgac tgtttatttc
tttgccgatg gagtccacaa 420 gtcttaccct ggacagcgga ccaaggatgc
tatagtaacc tggatcaaga agaagatcgg 480 acctggtatt tacaacataa
cttcggtgga agatgctgaa cgcatactga cttctgagac 540 taaagttgtt
cttggttacc tgaactcctt ggtgggccct gagagcaatg agcttgctgc 600
tgcttcaaga ctggaagatg atgtcaactt ttaccaaacg gtggatcctg aagtggccaa
660 gcttttccac attgaagctt cagcaaaacg ccctgccttg gtattgctta
agaaggaggc 720 tgaaaaactg aaccgctttg atggcgagtt ttctaagtct
gcaattgctg aatttgtgtt 780 tgccaataag cttccattag ttacaaagtt
tacgagagaa agcgcaccat tgattttcga 840 aagttcaatt aagaaacagt
tgattctatt tgcgatttca aatgattcag agaaactaat 900 ccccatattt
gaagagtcgt cgaagtcttt taaaggaaag cttattttcg tttatgtgga 960
aattgacaat gaagatgttg gaaagccggt atcagaatac tttggcatta gtggcaatgg
1020 tccagaggtt cttggataca ctggaaatga ggacagcaag aaatttgtgc
ttgctaagga 1080 agttactttg gataatatta aggctttcgg agaaaatttc
ttggaagaca agttaaaacc 1140 cttttataag tcagatccca ttcctgagac
taatgatggt gacgtgaaag tagtggttgg 1200 agacaacttc gacaatattg
ttttagatga atcgaaggat gttctcctcg agatctatgc 1260 tccttggtgt
gggcattgcc aagcactgga accaacttat aacaagcttg ccaaacattt 1320
acgtggcatc gattcacttg tcattgctaa gatggatggc acaacaaatg aacatccccg
1380 ggcgaagtcc gatggattcc caacaattct gtttttccca gctggaaaca
agagctttga 1440 ccctatcact gtcgataccg atcgtaccgt tgtggcactg
tacaaattca tcaagaaaaa 1500 tgcatccatc cctttcaagc tacagaagcc
agtttcgagt ccgaaagccg taagttctga 1560 agccaaatct ggtgatgcca
aagagagccc aaagagcagc accactgacg taaaggatga 1620 attgtgaaga
cttcttaaat agttttgtaa gttattatcc catcttttat gcactttttg 1680
cagctgccag atttttagac catatggaga gactagaaat taaaagaaaa tgtttttttc
1740 cctttttctt taggaaaaaa aaaaaaaaaa aaaa 1774 8 541 PRT Momordica
charantia 8 His Glu Glu Pro Asp Ala Ala Ala Gly Ala Ser Ala His Arg
His Leu 1 5 10 15 Pro Asp Phe Asp Gly Phe Glu Gly Gly Ala Glu Asp
Glu Asp Phe Gly 20 25 30 Asp Phe Ser Asp Phe Glu Asp Ser Asp Ala
Asp Arg Asp Glu Tyr Lys 35 40 45 Ala Pro Glu Val Asp Glu Lys Asp
Val Val Val Leu Lys Glu Gly Asn 50 55 60 Phe Ser Asp Phe Val Glu
Lys Asn Arg Phe Val Met Val Glu Phe Tyr 65 70 75 80 Ala Pro Trp Cys
Gly His Cys Gln Ala Leu Ala Pro Glu Tyr Ala Ala 85 90 95 Ala Ala
Thr Glu Leu Lys Gly Glu Asn Val Val Leu Ala Lys Val Asp 100 105 110
Ala Thr Glu Glu Asn Glu Leu Ser Gln Lys Tyr Asp Val Gln Gly Phe 115
120 125 Pro Thr Val Tyr Phe Phe Ala Asp Gly Val His Lys Ser Tyr Pro
Gly 130 135 140 Gln Arg Thr Lys Asp Ala Ile Val Thr Trp Ile Lys Lys
Lys Ile Gly 145 150 155 160 Pro Gly Ile Tyr Asn Ile Thr Ser Val Glu
Asp Ala Glu Arg Ile Leu 165 170 175 Thr Ser Glu Thr Lys Val Val Leu
Gly Tyr Leu Asn Ser Leu Val Gly 180 185 190 Pro Glu Ser Asn Glu Leu
Ala Ala Ala Ser Arg Leu Glu Asp Asp Val 195 200 205 Asn Phe Tyr Gln
Thr Val Asp Pro Glu Val Ala Lys Leu Phe His Ile 210 215 220 Glu Ala
Ser Ala Lys Arg Pro Ala Leu Val Leu Leu Lys Lys Glu Ala 225 230 235
240 Glu Lys Leu Asn Arg Phe Asp Gly Glu Phe Ser Lys Ser Ala Ile Ala
245 250 255 Glu Phe Val Phe Ala Asn Lys Leu Pro Leu Val Thr Lys Phe
Thr Arg 260 265 270 Glu Ser Ala Pro Leu Ile Phe Glu Ser Ser Ile Lys
Lys Gln Leu Ile 275 280 285 Leu Phe Ala Ile Ser Asn Asp Ser Glu Lys
Leu Ile Pro Ile Phe Glu 290 295 300 Glu Ser Ser Lys Ser Phe Lys Gly
Lys Leu Ile Phe Val Tyr Val Glu 305 310 315 320 Ile Asp Asn Glu Asp
Val Gly Lys Pro Val Ser Glu Tyr Phe Gly Ile 325 330 335 Ser Gly Asn
Gly Pro Glu Val Leu Gly Tyr Thr Gly Asn Glu Asp Ser 340 345 350 Lys
Lys Phe Val Leu Ala Lys Glu Val Thr Leu Asp Asn Ile Lys Ala 355 360
365 Phe Gly Glu Asn Phe Leu Glu Asp Lys Leu Lys Pro Phe Tyr Lys Ser
370 375 380 Asp Pro Ile Pro Glu Thr Asn Asp Gly Asp Val Lys Val Val
Val Gly 385 390 395 400 Asp Asn Phe Asp Asn Ile Val Leu Asp Glu Ser
Lys Asp Val Leu Leu 405 410 415 Glu Ile Tyr Ala Pro Trp Cys Gly His
Cys Gln Ala Leu Glu Pro Thr 420 425 430 Tyr Asn Lys Leu Ala Lys His
Leu Arg Gly Ile Asp Ser Leu Val Ile 435 440 445 Ala Lys Met Asp Gly
Thr Thr Asn Glu His Pro Arg Ala Lys Ser Asp 450 455 460 Gly Phe Pro
Thr Ile Leu Phe Phe Pro Ala Gly Asn Lys Ser Phe Asp 465 470 475 480
Pro Ile Thr Val Asp Thr Asp Arg Thr Val Val Ala Leu Tyr Lys Phe 485
490 495 Ile Lys Lys Asn Ala Ser Ile Pro Phe Lys Leu Gln Lys Pro Val
Ser 500 505 510 Ser Pro Lys Ala Val Ser Ser Glu Ala Lys Ser Gly Asp
Ala Lys Glu 515 520 525 Ser Pro Lys Ser Ser Thr Thr Asp Val Lys Asp
Glu Leu 530 535 540 9 2031 DNA Zea mays 9 ctcaccagct gcccgcgcat
ccaattcctc tcgctggacg gctgcagcac atcatcaggt 60 gagaccgtga
gagggaatgg gatcaacaac aatgtcccct ccatcttttc ccgtcgtcct 120
cctgctcctc ctcctcgcca ccatagccgc agccgccgga agcaacatgg atgaggaggt
180 ggtggacgac ctccagtatc ttattgacaa ctccgacgac atccccacca
acgatcccga 240 cgggtggcct gagggagact acgacgacga cgaccttctc
ttccaagatc aggaccagga 300 cctcacaggc caccagccgg agatcgacga
gacccacgta gtggtcctcg ccgccgcaaa 360 cttttcctcc ttcctcgcct
ccagccacca tgttatggtt gagttctacg caccttggtg 420 tggccactgc
caggagctcg ccccgggatt aagccggcgc cgcgcgcatc tcgccggctc 480
aaccaaccaa ccaaggccca acttcgccct tgccaaggtc gacgccaccg aggaaaccga
540 cctcgcccag aagtacgacg tccagggctt ccccaccatc ctcttcttca
tcgatggcgt 600 ccccagaggc tataacggag ccaggaccaa ggaagccatc
gtcgactgga tcaacaagaa 660 gctcggccca gccgtgcaaa atgtcaccag
cgtcgacgag gcccagagca tactcaccgg 720 agatgacaaa gccgtccttg
ccttcctcga cacactatcc ggtgctcaca gtgatgagct 780 tgctgctgct
tcgaggctgg aagatagcat caacttttat cagacttcga ctcctgatgt 840
tgctaagctt ttccatatcg atgcagcagc gaagcgtcca tccgtagtgc tgctgaagaa
900 agaggaggag aagttgacct tctatgatgg ggagtttaaa gcatcagcca
ttgctggttt 960 tgtgtctgct aacaagcttc ctttggtgac cacactaact
caagaaactt ccccttctat 1020 ttttggcaat ccaatcaaga agcagatttt
actatttgct gttgcaagcg agtccaccaa 1080 atttctgccc atctttaagg
aagcagcaaa accatttaag ggaaagttat tatttgtctt 1140 tgtggaacga
gacagtgagg aagttggtga accagttgcc gactactttg gtattactgg 1200
acaagagacc acagttcttg cttacactgg taatgaagat gctaggaaat tttttcttga
1260 tggtgaggtg tcacttgaag ctataaagga cttcgctgaa ggtttcttgg
aagacaagct 1320 tacaccattc tacaaatcgg aaccagtgcc tgaatctaat
gatggggatg tgaaaattgt 1380 tgttgggaag aatctggatc taatagtttt
tgatgaaaca aaagatgtac ttcttgagat 1440 atatgcacca tggtgtggtc
attgtcaatc gctggaacct acttacaaca atctagccaa 1500 gcatctacgt
agtgttgact cccttgtggt agccaaaatg gatggtacta ccaatgagca 1560
tccacgtgca aagtctgacg gatacccgac gattctcttc tatccagctg ggaagaaaag
1620 ctttgagcca atcacttttg agggggagcg gacagtggta gatctgtaca
agttcatcaa 1680 gaaacatgct agcatccctt tcaagttgaa gcgccaggag
tcgagaaccg agagcactcg 1740 ggcggagggt gtgaagagct ctggtacgaa
ctcaaaggac gaactgtaaa gagctcaggg 1800 ttggatgtgt gttggagtgg
atcagggtga aagtttccat ctcaatacaa gtagatcgat 1860 cttggtggat
gcgagtgcag tgttggcctg agggaggagc agcagagatg agtgcttact 1920
gcttagagag aggaatgaaa tcagcaacta atcaaataaa atcaaattcc attaaaaaaa
1980 aaaaaaaaaa taaaaaaaaa aaaattaaaa aaaaataaaa aaaaaaaaaa a 2031
10 570 PRT Zea mays 10 Met Gly Ser Thr Thr Met Ser Pro Pro Ser Phe
Pro Val Val Leu Leu 1 5 10 15 Leu Leu Leu Leu Ala Thr Ile Ala Ala
Ala Ala Gly Ser Asn Met Asp 20 25 30 Glu Glu Val Val Asp Asp Leu
Gln Tyr Leu Ile Asp Asn Ser Asp Asp 35 40 45 Ile Pro Thr Asn Asp
Pro Asp Gly Trp Pro Glu Gly Asp Tyr Asp Asp 50 55 60 Asp Asp Leu
Leu Phe Gln Asp Gln Asp Gln Asp Leu Thr Gly His Gln 65 70 75 80 Pro
Glu Ile Asp Glu Thr His Val Val Val Leu Ala Ala Ala Asn Phe 85
90
95 Ser Ser Phe Leu Ala Ser Ser His His Val Met Val Glu Phe Tyr Ala
100 105 110 Pro Trp Cys Gly His Cys Gln Glu Leu Ala Pro Gly Leu Ser
Arg Arg 115 120 125 Arg Ala His Leu Ala Gly Ser Thr Asn Gln Pro Arg
Pro Asn Phe Ala 130 135 140 Leu Ala Lys Val Asp Ala Thr Glu Glu Thr
Asp Leu Ala Gln Lys Tyr 145 150 155 160 Asp Val Gln Gly Phe Pro Thr
Ile Leu Phe Phe Ile Asp Gly Val Pro 165 170 175 Arg Gly Tyr Asn Gly
Ala Arg Thr Lys Glu Ala Ile Val Asp Trp Ile 180 185 190 Asn Lys Lys
Leu Gly Pro Ala Val Gln Asn Val Thr Ser Val Asp Glu 195 200 205 Ala
Gln Ser Ile Leu Thr Gly Asp Asp Lys Ala Val Leu Ala Phe Leu 210 215
220 Asp Thr Leu Ser Gly Ala His Ser Asp Glu Leu Ala Ala Ala Ser Arg
225 230 235 240 Leu Glu Asp Ser Ile Asn Phe Tyr Gln Thr Ser Thr Pro
Asp Val Ala 245 250 255 Lys Leu Phe His Ile Asp Ala Ala Ala Lys Arg
Pro Ser Val Val Leu 260 265 270 Leu Lys Lys Glu Glu Glu Lys Leu Thr
Phe Tyr Asp Gly Glu Phe Lys 275 280 285 Ala Ser Ala Ile Ala Gly Phe
Val Ser Ala Asn Lys Leu Pro Leu Val 290 295 300 Thr Thr Leu Thr Gln
Glu Thr Ser Pro Ser Ile Phe Gly Asn Pro Ile 305 310 315 320 Lys Lys
Gln Ile Leu Leu Phe Ala Val Ala Ser Glu Ser Thr Lys Phe 325 330 335
Leu Pro Ile Phe Lys Glu Ala Ala Lys Pro Phe Lys Gly Lys Leu Leu 340
345 350 Phe Val Phe Val Glu Arg Asp Ser Glu Glu Val Gly Glu Pro Val
Ala 355 360 365 Asp Tyr Phe Gly Ile Thr Gly Gln Glu Thr Thr Val Leu
Ala Tyr Thr 370 375 380 Gly Asn Glu Asp Ala Arg Lys Phe Phe Leu Asp
Gly Glu Val Ser Leu 385 390 395 400 Glu Ala Ile Lys Asp Phe Ala Glu
Gly Phe Leu Glu Asp Lys Leu Thr 405 410 415 Pro Phe Tyr Lys Ser Glu
Pro Val Pro Glu Ser Asn Asp Gly Asp Val 420 425 430 Lys Ile Val Val
Gly Lys Asn Leu Asp Leu Ile Val Phe Asp Glu Thr 435 440 445 Lys Asp
Val Leu Leu Glu Ile Tyr Ala Pro Trp Cys Gly His Cys Gln 450 455 460
Ser Leu Glu Pro Thr Tyr Asn Asn Leu Ala Lys His Leu Arg Ser Val 465
470 475 480 Asp Ser Leu Val Val Ala Lys Met Asp Gly Thr Thr Asn Glu
His Pro 485 490 495 Arg Ala Lys Ser Asp Gly Tyr Pro Thr Ile Leu Phe
Tyr Pro Ala Gly 500 505 510 Lys Lys Ser Phe Glu Pro Ile Thr Phe Glu
Gly Glu Arg Thr Val Val 515 520 525 Asp Leu Tyr Lys Phe Ile Lys Lys
His Ala Ser Ile Pro Phe Lys Leu 530 535 540 Lys Arg Gln Glu Ser Arg
Thr Glu Ser Thr Arg Ala Glu Gly Val Lys 545 550 555 560 Ser Ser Gly
Thr Asn Ser Lys Asp Glu Leu 565 570 11 891 DNA Zea mays 11
gcacgagtgg aaatggataa cgaagatgtt ggaaagcctg tttcagaata ctttggtatc
60 agtgggaatg ctccaaaagt acttggatac actgggaatg atgatggaaa
aaaatttgtg 120 cttgatggag aggtgactac tgacaaaatt aaggcatttg
gggaagattt cgttgaagac 180 aagctaaaac ctttttacaa gtcagatcca
gttcctgaaa gtaatgatgg tgatgtgaaa 240 atagtagttg gtaataattt
tgatgaaatt gtcttggatg agtcaaagga tgttctcctc 300 gagatttatg
ctccctggtg tggccattgc caatcactgg agccaatata caacaagctt 360
gcaaaacatc ttcgcaatat tgattctctt gtaatagcca agatggatgg aacaacaaat
420 gagcatccca gggctaagcc tgatggattc cccactcttc tcttcttccc
ggcaggaaac 480 aagagttttg accctattac tgttgataca gatcgtacag
tggtagcctt ctacaagttc 540 ctcaagaaac atgcatcaat cccattcaag
ctccagaaac caacctcaac ttctgaatcc 600 gattccaagg ggagctctga
tgccaaagag agccagagta gtgatgtgaa ggacgaatta 660 tgaggagtta
agtgatatat ttttatttat agaaactatg attcagacag atgatgacat 720
agtgactgag gtaaaaaata ccaagttact tctcacccct ggtcaataaa aaacaaacgg
780 ggagtggggg gagagagaca aatgcgaggc acacatgtat tactattaac
ttcaatttgt 840 acaacagtgg gtaatttaga attttgattt tgggttgaga
cttcaaaaaa a 891 12 220 PRT Zea mays 12 Ala Arg Val Glu Met Asp Asn
Glu Asp Val Gly Lys Pro Val Ser Glu 1 5 10 15 Tyr Phe Gly Ile Ser
Gly Asn Ala Pro Lys Val Leu Gly Tyr Thr Gly 20 25 30 Asn Asp Asp
Gly Lys Lys Phe Val Leu Asp Gly Glu Val Thr Thr Asp 35 40 45 Lys
Ile Lys Ala Phe Gly Glu Asp Phe Val Glu Asp Lys Leu Lys Pro 50 55
60 Phe Tyr Lys Ser Asp Pro Val Pro Glu Ser Asn Asp Gly Asp Val Lys
65 70 75 80 Ile Val Val Gly Asn Asn Phe Asp Glu Ile Val Leu Asp Glu
Ser Lys 85 90 95 Asp Val Leu Leu Glu Ile Tyr Ala Pro Trp Cys Gly
His Cys Gln Ser 100 105 110 Leu Glu Pro Ile Tyr Asn Lys Leu Ala Lys
His Leu Arg Asn Ile Asp 115 120 125 Ser Leu Val Ile Ala Lys Met Asp
Gly Thr Thr Asn Glu His Pro Arg 130 135 140 Ala Lys Pro Asp Gly Phe
Pro Thr Leu Leu Phe Phe Pro Ala Gly Asn 145 150 155 160 Lys Ser Phe
Asp Pro Ile Thr Val Asp Thr Asp Arg Thr Val Val Ala 165 170 175 Phe
Tyr Lys Phe Leu Lys Lys His Ala Ser Ile Pro Phe Lys Leu Gln 180 185
190 Lys Pro Thr Ser Thr Ser Glu Ser Asp Ser Lys Gly Ser Ser Asp Ala
195 200 205 Lys Glu Ser Gln Ser Ser Asp Val Lys Asp Glu Leu 210 215
220 13 1126 DNA Glycine max 13 gcacgagcaa gtttccatta gttacaaagc
tgactgaaat gaattctatc agagtctact 60 ccagccccat caagcttcag
gttttagtct ttgcaaacat tgatgacttc aagaatcttc 120 ttgaaactct
tcaagatgtt gcaaaaacat tcaagtcaaa gataatgttt atatatgtgg 180
atattaatga tgagaacctt gcaaagccct tcttaacatt gtttggtctt gaagaatcaa
240 aaaatactgt ggtcgccgca tttgataatg caatgagctc aaaatatttg
ttggagacaa 300 aaccaacaca aagcaatatt gaagagttct gcaataacct
tgtgcaaggg tctttgtcac 360 cttacttcaa gtcacagcca attccagata
atacagaatc aagtgtccat gttattgtcg 420 ggaaaacatt tgatgatgaa
atcttgagca gcgagaagga tgtgctcttg gaggtattta 480 cgccttggtg
catcaactgt gaggccacta gcaagcaagt agagaagttg gcaaagcact 540
acaaaggatc aagtaatcta atatttgcaa ggatagatgc ttcagcaaat gaacatccaa
600 aactgcaagt gaatgactac cccacgcttc tactttacag agcagacgat
aaggcaaatc 660 cgatcaaact ttccacaaaa tctagtttga aagagttggc
tgcatccatt aacaaatatg 720 taaaagtcaa gaatcaagtc gtcaaagatg
agttatagaa catatcaaaa agttttggga 780 gaaaaacact taaccatgaa
gaaagtaaaa cattatggaa agaaacaaat attatgttgt 840 cttgcgtaag
cattttctaa tttttattaa cctttcccct gccattttat ggtggtccaa 900
atatgagtta gtctattatt atttgagtta gcttactgct aaattgcgaa agctagtcaa
960 attataacat gtaatgaact acagaacata cttgatacac caaacattgt
accgatcaac 1020 actttccatt tgcatctcat agaaacctgc aaatcacagg
cttaaagttg atgcattgac 1080 acatatcaaa ctcaagcttt tataattcga
aaaaaaaaaa aaaaaa 1126 14 251 PRT Glycine max 14 Thr Ser Lys Phe
Pro Leu Val Thr Lys Leu Thr Glu Met Asn Ser Ile 1 5 10 15 Arg Val
Tyr Ser Ser Pro Ile Lys Leu Gln Val Leu Val Phe Ala Asn 20 25 30
Ile Asp Asp Phe Lys Asn Leu Leu Glu Thr Leu Gln Asp Val Ala Lys 35
40 45 Thr Phe Lys Ser Lys Ile Met Phe Ile Tyr Val Asp Ile Asn Asp
Glu 50 55 60 Asn Leu Ala Lys Pro Phe Leu Thr Leu Phe Gly Leu Glu
Glu Ser Lys 65 70 75 80 Asn Thr Val Val Ala Ala Phe Asp Asn Ala Met
Ser Ser Lys Tyr Leu 85 90 95 Leu Glu Thr Lys Pro Thr Gln Ser Asn
Ile Glu Glu Phe Cys Asn Asn 100 105 110 Leu Val Gln Gly Ser Leu Ser
Pro Tyr Phe Lys Ser Gln Pro Ile Pro 115 120 125 Asp Asn Thr Glu Ser
Ser Val His Val Ile Val Gly Lys Thr Phe Asp 130 135 140 Asp Glu Ile
Leu Ser Ser Glu Lys Asp Val Leu Leu Glu Val Phe Thr 145 150 155 160
Pro Trp Cys Ile Asn Cys Glu Ala Thr Ser Lys Gln Val Glu Lys Leu 165
170 175 Ala Lys His Tyr Lys Gly Ser Ser Asn Leu Ile Phe Ala Arg Ile
Asp 180 185 190 Ala Ser Ala Asn Glu His Pro Lys Leu Gln Val Asn Asp
Tyr Pro Thr 195 200 205 Leu Leu Leu Tyr Arg Ala Asp Asp Lys Ala Asn
Pro Ile Lys Leu Ser 210 215 220 Thr Lys Ser Ser Leu Lys Glu Leu Ala
Ala Ser Ile Asn Lys Tyr Val 225 230 235 240 Lys Val Lys Asn Gln Val
Val Lys Asp Glu Leu 245 250 15 1943 DNA Glycine max 15 gttctcttca
ctctcacaat gcgaatcctc gttgtgctct ctctcgccac cctcctcctc 60
ttctcctccc tctttctcac cctctgcgac gacctcaccg acgacgagga cctcggcttc
120 ctcgacgagc cctccgccgc gccggagcac ggccactacc acgacgatga
cgccaatttc 180 ggcgacttcg aggaggaccc ggaggcgtac aagcagcccg
aggtggacga gaaggacgtc 240 gtcattttga aggagaagaa cttcaccgac
accgtcaaga gcaaccgctt cgtcatggtc 300 gagttctacg cgccctggtg
cggccactgc caggccctcg cgccggagta cgccgccgcc 360 gcgacggaac
tcaagggcga agacgtaatt ttggcaaagg tggatgccac cgaggagaat 420
gaattggcgc agcagtacga tgttcagggt ttccccactg tccacttctt cgttgatggc
480 attcacaagc cttataatgg ccaaaggacc aaagatgcta tagtgacgtg
gataggaaag 540 aagatcggac ctggcatata caacttgact acagtggagg
atgctcaacg catcttgacc 600 aacgaaacta aagttgtttt gggcttcctc
aactctttag ttggtcctga gagtgaggag 660 cttgctgctg cttcaagact
tgaggatgat gtcaattttt atcaaactgt ggatcctgat 720 gtggcaaagc
ttttccatat tgacccagat gttaagcgcc cagctttgat cctcgtcaag 780
aaagaggagg aaaaacttaa ccactttgat ggcaaatttg agaagtcgga aatagcagac
840 tttgtcttct ccaacaagct tcctttggta acaattttta caagagaaag
tgccccatca 900 gtcttcgaaa atccaatcaa gaaacagttg ttgctgtttg
caacttcaaa tgattcagag 960 aagttgatcc ctgcatttaa agaagctgca
aaatctttca agggaaagtt gatctttgta 1020 tatgtggaaa tggataacga
agatgttgga aagcctgttt cagaatactt tggtatcagt 1080 gggaatgctc
caaaagtact tgggtacact gggaatgatg atggaaaaaa atttgtgctt 1140
gatggagagg tgactgctga caaaattaag gcatttgggg acgatttcct tgaagacaag
1200 ctaaaacctt tttacaagtc agatccagtt cctgaaagta atgatggtga
tgtgaaaata 1260 gtagttggga ataattttga tgaaattgtc ttggatgagt
caaaggatgt tctcctcgag 1320 atttatgctc cctggtgtgg ccattgccaa
gcactggagc caatatacga caagcttgca 1380 aaacatcttc gtaatattga
gtctcttgta atagccaaga tggatggaac aacaaatgag 1440 catcccaggg
ctaagcctga tggatttccc actctcctct tcttcccggc aggaaacaag 1500
agttttgacc ctattactgt tgatacagat cgtacagtgg tagccttcta caagttcctc
1560 aagaaacatg catcaatccc attcaagctc cagaaaccaa cctcaacttc
tgatgccaag 1620 gggagctctg atgccaaaga gagccagagt agtgatgtga
aggatgaatt atgaggagtt 1680 aagtgatata tttttattta ttgaaactga
ttcagacaga tgatgacatg gtgactgagg 1740 gagaaaatac caagctgctt
ctctccccta gccaataaaa acaaacgagg agtgggggga 1800 aggagacaaa
tgcgaggcac atatgtatta ctattaactt aaatttttac aactgggcat 1860
tttagaattt tgggttgaga cttcaataaa ttccccctta aattttaaaa aaaaaaaaaa
1920 aaaaaaaaac tcgagactag ttc 1943 16 551 PRT Glycine max 16 Met
Arg Ile Leu Val Val Leu Ser Leu Ala Thr Leu Leu Leu Phe Ser 1 5 10
15 Ser Leu Phe Leu Thr Leu Cys Asp Asp Leu Thr Asp Asp Glu Asp Leu
20 25 30 Gly Phe Leu Asp Glu Pro Ser Ala Ala Pro Glu His Gly His
Tyr His 35 40 45 Asp Asp Asp Ala Asn Phe Gly Asp Phe Glu Glu Asp
Pro Glu Ala Tyr 50 55 60 Lys Gln Pro Glu Val Asp Glu Lys Asp Val
Val Ile Leu Lys Glu Lys 65 70 75 80 Asn Phe Thr Asp Thr Val Lys Ser
Asn Arg Phe Val Met Val Glu Phe 85 90 95 Tyr Ala Pro Trp Cys Gly
His Cys Gln Ala Leu Ala Pro Glu Tyr Ala 100 105 110 Ala Ala Ala Thr
Glu Leu Lys Gly Glu Asp Val Ile Leu Ala Lys Val 115 120 125 Asp Ala
Thr Glu Glu Asn Glu Leu Ala Gln Gln Tyr Asp Val Gln Gly 130 135 140
Phe Pro Thr Val His Phe Phe Val Asp Gly Ile His Lys Pro Tyr Asn 145
150 155 160 Gly Gln Arg Thr Lys Asp Ala Ile Val Thr Trp Ile Gly Lys
Lys Ile 165 170 175 Gly Pro Gly Ile Tyr Asn Leu Thr Thr Val Glu Asp
Ala Gln Arg Ile 180 185 190 Leu Thr Asn Glu Thr Lys Val Val Leu Gly
Phe Leu Asn Ser Leu Val 195 200 205 Gly Pro Glu Ser Glu Glu Leu Ala
Ala Ala Ser Arg Leu Glu Asp Asp 210 215 220 Val Asn Phe Tyr Gln Thr
Val Asp Pro Asp Val Ala Lys Leu Phe His 225 230 235 240 Ile Asp Pro
Asp Val Lys Arg Pro Ala Leu Ile Leu Val Lys Lys Glu 245 250 255 Glu
Glu Lys Leu Asn His Phe Asp Gly Lys Phe Glu Lys Ser Glu Ile 260 265
270 Ala Asp Phe Val Phe Ser Asn Lys Leu Pro Leu Val Thr Ile Phe Thr
275 280 285 Arg Glu Ser Ala Pro Ser Val Phe Glu Asn Pro Ile Lys Lys
Gln Leu 290 295 300 Leu Leu Phe Ala Thr Ser Asn Asp Ser Glu Lys Leu
Ile Pro Ala Phe 305 310 315 320 Lys Glu Ala Ala Lys Ser Phe Lys Gly
Lys Leu Ile Phe Val Tyr Val 325 330 335 Glu Met Asp Asn Glu Asp Val
Gly Lys Pro Val Ser Glu Tyr Phe Gly 340 345 350 Ile Ser Gly Asn Ala
Pro Lys Val Leu Gly Tyr Thr Gly Asn Asp Asp 355 360 365 Gly Lys Lys
Phe Val Leu Asp Gly Glu Val Thr Ala Asp Lys Ile Lys 370 375 380 Ala
Phe Gly Asp Asp Phe Leu Glu Asp Lys Leu Lys Pro Phe Tyr Lys 385 390
395 400 Ser Asp Pro Val Pro Glu Ser Asn Asp Gly Asp Val Lys Ile Val
Val 405 410 415 Gly Asn Asn Phe Asp Glu Ile Val Leu Asp Glu Ser Lys
Asp Val Leu 420 425 430 Leu Glu Ile Tyr Ala Pro Trp Cys Gly His Cys
Gln Ala Leu Glu Pro 435 440 445 Ile Tyr Asp Lys Leu Ala Lys His Leu
Arg Asn Ile Glu Ser Leu Val 450 455 460 Ile Ala Lys Met Asp Gly Thr
Thr Asn Glu His Pro Arg Ala Lys Pro 465 470 475 480 Asp Gly Phe Pro
Thr Leu Leu Phe Phe Pro Ala Gly Asn Lys Ser Phe 485 490 495 Asp Pro
Ile Thr Val Asp Thr Asp Arg Thr Val Val Ala Phe Tyr Lys 500 505 510
Phe Leu Lys Lys His Ala Ser Ile Pro Phe Lys Leu Gln Lys Pro Thr 515
520 525 Ser Thr Ser Asp Ala Lys Gly Ser Ser Asp Ala Lys Glu Ser Gln
Ser 530 535 540 Ser Asp Val Lys Asp Glu Leu 545 550 17 1565 DNA
Triticum aestivum 17 gcacgagacc acgcggagct gctgctgctc gggtacgcgc
cgtggtgtga gcgcagcgcg 60 cagctcatgc cgcggttcgc cgaggccgcc
gccgcgctgc gcgccatggg cagcgccgtc 120 gccttcgcga agctcgacgg
ggagcgctac cccaaggcgg ctgccgccgt cggggtcaag 180 ggcttcccca
ccgtgctcct cttcgtcaat ggcaccgagc acgcctacca tggcctccac 240
accaaggacg ccatagttac ttgggtaaga aagaaaactg gcgagccaat cattaggctt
300 cagtctaagg attcagctga ggagttcctc aaaaaggaca tgacctttgt
tattgggcta 360 ttcaagaatt ttgagggagc agaccatgaa gaatttgtga
aggcagcaac cacagacaac 420 gaggtacagt ttgtagaaac cagtgataca
cgtgttgcca aagttctatt tccaggtatt 480 acgtccgagg agaaatttgt
gggcctcgtt aaaagcgagc cagagaagtt tgaaaagttc 540 gatgggaaat
ttgaagaaac ggaaattctg cggtttgtgg agctcaacaa gtttcctcta 600
attactgtat tcactgagct caattccggt aaagtatatt caagccctat taagctacag
660 gtcttcacct ttgcagaggc ttatgatttt gaagatctgg aatctatggt
tgaagaaata 720 gccagagcat tcaagacaaa gataatgttt atatatgttg
acactgctga agaaaacctt 780 gcaaaaccat tcctcactct ttatggcctt
gaatcagaaa aaaagcctac tgttacagca 840 tttgatacaa gcaatggagc
caagtatctg atggaggcag atatcaatgc aaacaacctg 900 agggagttct
gcttaagtct tctggatggc acgctcccgc cataccacaa atcagaacca 960
ttgcctcaag agaagggact tattgaaaag gttgttggtc gtacatttga ttcttctgtg
1020 ctggaaagtc atcaaaacgt cttccttgag gttcatacac cttggtgtgt
tgactgtgaa 1080 gcgataagta aaaatgttga gaagttggcg aagcatttca
gtggttcgga caatcttaaa 1140 tttgcacgca tagatgcttc tgtgaatgaa
catcccaaat tgaaggtgaa taattccccg 1200 acgctattcc tttatcttgc
tgaagacaaa aacaacccga tcaagctttc aaagaaatcg 1260 agtgtcaagg
acatggccaa actgatcaag gagaagctgc aaataccaga cgtggagaca 1320
gtagcggccc ctgacaacgt caaggatgag ctataacctg tagtagacaa actaaggtcc
1380 agtgaaggaa aaattgcagc atgtttgcgt gttttgcccc aacctgatca
cagagctcag 1440 ctttattcgc gtgctgtgtt aagttgacta aagtcaatgg
tatataatat aggtacctaa 1500 atcaaagagg cttcggcccc taaaaaaaaa
aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa 1560 aaaaa 1565 18 451 PRT
Triticum aestivum 18 Ala Arg Asp His Ala Glu Leu Leu Leu
Leu Gly Tyr Ala Pro Trp Cys 1 5 10 15 Glu Arg Ser Ala Gln Leu Met
Pro Arg Phe Ala Glu Ala Ala Ala Ala 20 25 30 Leu Arg Ala Met Gly
Ser Ala Val Ala Phe Ala Lys Leu Asp Gly Glu 35 40 45 Arg Tyr Pro
Lys Ala Ala Ala Ala Val Gly Val Lys Gly Phe Pro Thr 50 55 60 Val
Leu Leu Phe Val Asn Gly Thr Glu His Ala Tyr His Gly Leu His 65 70
75 80 Thr Lys Asp Ala Ile Val Thr Trp Val Arg Lys Lys Thr Gly Glu
Pro 85 90 95 Ile Ile Arg Leu Gln Ser Lys Asp Ser Ala Glu Glu Phe
Leu Lys Lys 100 105 110 Asp Met Thr Phe Val Ile Gly Leu Phe Lys Asn
Phe Glu Gly Ala Asp 115 120 125 His Glu Glu Phe Val Lys Ala Ala Thr
Thr Asp Asn Glu Val Gln Phe 130 135 140 Val Glu Thr Ser Asp Thr Arg
Val Ala Lys Val Leu Phe Pro Gly Ile 145 150 155 160 Thr Ser Glu Glu
Lys Phe Val Gly Leu Val Lys Ser Glu Pro Glu Lys 165 170 175 Phe Glu
Lys Phe Asp Gly Lys Phe Glu Glu Thr Glu Ile Leu Arg Phe 180 185 190
Val Glu Leu Asn Lys Phe Pro Leu Ile Thr Val Phe Thr Glu Leu Asn 195
200 205 Ser Gly Lys Val Tyr Ser Ser Pro Ile Lys Leu Gln Val Phe Thr
Phe 210 215 220 Ala Glu Ala Tyr Asp Phe Glu Asp Leu Glu Ser Met Val
Glu Glu Ile 225 230 235 240 Ala Arg Ala Phe Lys Thr Lys Ile Met Phe
Ile Tyr Val Asp Thr Ala 245 250 255 Glu Glu Asn Leu Ala Lys Pro Phe
Leu Thr Leu Tyr Gly Leu Glu Ser 260 265 270 Glu Lys Lys Pro Thr Val
Thr Ala Phe Asp Thr Ser Asn Gly Ala Lys 275 280 285 Tyr Leu Met Glu
Ala Asp Ile Asn Ala Asn Asn Leu Arg Glu Phe Cys 290 295 300 Leu Ser
Leu Leu Asp Gly Thr Leu Pro Pro Tyr His Lys Ser Glu Pro 305 310 315
320 Leu Pro Gln Glu Lys Gly Leu Ile Glu Lys Val Val Gly Arg Thr Phe
325 330 335 Asp Ser Ser Val Leu Glu Ser His Gln Asn Val Phe Leu Glu
Val His 340 345 350 Thr Pro Trp Cys Val Asp Cys Glu Ala Ile Ser Lys
Asn Val Glu Lys 355 360 365 Leu Ala Lys His Phe Ser Gly Ser Asp Asn
Leu Lys Phe Ala Arg Ile 370 375 380 Asp Ala Ser Val Asn Glu His Pro
Lys Leu Lys Val Asn Asn Ser Pro 385 390 395 400 Thr Leu Phe Leu Tyr
Leu Ala Glu Asp Lys Asn Asn Pro Ile Lys Leu 405 410 415 Ser Lys Lys
Ser Ser Val Lys Asp Met Ala Lys Leu Ile Lys Glu Lys 420 425 430 Leu
Gln Ile Pro Asp Val Glu Thr Val Ala Ala Pro Asp Asn Val Lys 435 440
445 Asp Glu Leu 450 19 1078 DNA Triticum aestivum 19 gcacgaggtt
cagagcatct gcgattgcca agtttgtttc ggccaacaaa atcccattga 60
tcaccaccct cacacaggag accgcccctg cgattttcga taatccgatc aagaagcaaa
120 ttttgctgtt tgctgttgcg aaggagtcct caaaatttct gcccatcatt
aaggaaacag 180 caaaatcatt caaggggaag cttttatttg tctttgtgga
gcgtgacaat gaggaagttg 240 gcgaacctgt tgccaattac tttggaatta
ctggacaaga gaccacggtt cttgcttaca 300 ctgggaatga agacgctaag
aagttcttct tcaccggtga aatatcactg gacaccatta 360 aggaatttgc
tcaagatttc atggaggaca agctcacacc atcctacaag tctgacccag 420
tacctgaatc caatgatgag gacgtcaaag ttgttgttgg caagagtcta gatcaaatag
480 ttctggatga gtcaaaggat gtccttttgg agatatatgc gccatggtgt
ggccattgtc 540 agtcactgga gcctatctac aacaagctgg ccaagtacct
ccgtggcatc gactcccttg 600 taatagccaa aatggacggc acaaacaatg
agcatcctcg tgccaagccc gatgggttcc 660 ccacgatact cttctaccca
gctgggaaga aaagctttga gcctataact ttcgaggggg 720 gccggacagt
ggtagagatg tacaagttcc tcaagaagca tgccgccatc cctttcaagc 780
tcaagcgccc ggactcgtca gcggcacgga ccgacagcgc cgagggccca ggctcgacca
840 ccgacagcga gaagagctcc ggctcgaacc cgaaggacga gttgtagggg
attgacaagt 900 acgaggaggc gccgatgatg tcgaaatcag gaggtggaga
aggaatggct aagctaggta 960 tcaaccaacc ttggctgctg caagtgtatg
ctgacaacac aaatattaac tgctgtagaa 1020 tccaataaaa taaaagcaag
aggtcctttt tcttagtact aaaaaaaaaa aaaaaaaa 1078 20 294 PRT Triticum
aestivum 20 Thr Arg Phe Arg Ala Ser Ala Ile Ala Lys Phe Val Ser Ala
Asn Lys 1 5 10 15 Ile Pro Leu Ile Thr Thr Leu Thr Gln Glu Thr Ala
Pro Ala Ile Phe 20 25 30 Asp Asn Pro Ile Lys Lys Gln Ile Leu Leu
Phe Ala Val Ala Lys Glu 35 40 45 Ser Ser Lys Phe Leu Pro Ile Ile
Lys Glu Thr Ala Lys Ser Phe Lys 50 55 60 Gly Lys Leu Leu Phe Val
Phe Val Glu Arg Asp Asn Glu Glu Val Gly 65 70 75 80 Glu Pro Val Ala
Asn Tyr Phe Gly Ile Thr Gly Gln Glu Thr Thr Val 85 90 95 Leu Ala
Tyr Thr Gly Asn Glu Asp Ala Lys Lys Phe Phe Phe Thr Gly 100 105 110
Glu Ile Ser Leu Asp Thr Ile Lys Glu Phe Ala Gln Asp Phe Met Glu 115
120 125 Asp Lys Leu Thr Pro Ser Tyr Lys Ser Asp Pro Val Pro Glu Ser
Asn 130 135 140 Asp Glu Asp Val Lys Val Val Val Gly Lys Ser Leu Asp
Gln Ile Val 145 150 155 160 Leu Asp Glu Ser Lys Asp Val Leu Leu Glu
Ile Tyr Ala Pro Trp Cys 165 170 175 Gly His Cys Gln Ser Leu Glu Pro
Ile Tyr Asn Lys Leu Ala Lys Tyr 180 185 190 Leu Arg Gly Ile Asp Ser
Leu Val Ile Ala Lys Met Asp Gly Thr Asn 195 200 205 Asn Glu His Pro
Arg Ala Lys Pro Asp Gly Phe Pro Thr Ile Leu Phe 210 215 220 Tyr Pro
Ala Gly Lys Lys Ser Phe Glu Pro Ile Thr Phe Glu Gly Gly 225 230 235
240 Arg Thr Val Val Glu Met Tyr Lys Phe Leu Lys Lys His Ala Ala Ile
245 250 255 Pro Phe Lys Leu Lys Arg Pro Asp Ser Ser Ala Ala Arg Thr
Asp Ser 260 265 270 Ala Glu Gly Pro Gly Ser Thr Thr Asp Ser Glu Lys
Ser Ser Gly Ser 275 280 285 Asn Pro Lys Asp Glu Leu 290
* * * * *
References